CN114480322B - Oat glycosyltransferase AsUGT73E5 and application thereof in steroid saponin synthesis - Google Patents
Oat glycosyltransferase AsUGT73E5 and application thereof in steroid saponin synthesis Download PDFInfo
- Publication number
- CN114480322B CN114480322B CN202011250301.1A CN202011250301A CN114480322B CN 114480322 B CN114480322 B CN 114480322B CN 202011250301 A CN202011250301 A CN 202011250301A CN 114480322 B CN114480322 B CN 114480322B
- Authority
- CN
- China
- Prior art keywords
- glycosyltransferase
- ala
- leu
- asugt73e5
- saponin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108700023372 Glycosyltransferases Proteins 0.000 title claims abstract description 51
- 102000051366 Glycosyltransferases Human genes 0.000 title claims abstract description 47
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 26
- 238000003786 synthesis reaction Methods 0.000 title claims abstract description 23
- 150000005856 steroid saponins Chemical class 0.000 title claims abstract description 20
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 103
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 65
- 229930182490 saponin Natural products 0.000 claims abstract description 31
- 150000007949 saponins Chemical class 0.000 claims abstract description 31
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 24
- SYYHBUHOUUETMI-WJOMMTHPSA-N pennogenin Chemical compound C([C@@]12[C@H]([C@@]3([C@@]4(C)CC[C@@H]5[C@@]6(C)CC[C@H](O)CC6=CC[C@H]5[C@@H]4C[C@@H]3O2)O)C)C[C@@H](C)CO1 SYYHBUHOUUETMI-WJOMMTHPSA-N 0.000 claims abstract description 22
- SYYHBUHOUUETMI-UHFFFAOYSA-N Pennogenin Natural products O1C2CC3C4CC=C5CC(O)CCC5(C)C4CCC3(C)C2(O)C(C)C21CCC(C)CO2 SYYHBUHOUUETMI-UHFFFAOYSA-N 0.000 claims abstract description 21
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 claims abstract description 20
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 claims abstract description 19
- HSCJRCZFDFQWRP-JZMIEXBBSA-N UDP-alpha-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-JZMIEXBBSA-N 0.000 claims abstract description 15
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000000758 substrate Substances 0.000 claims abstract description 8
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 5
- XCCTYIAWTASOJW-UHFFFAOYSA-N UDP-Glc Natural products OC1C(O)C(COP(O)(=O)OP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 XCCTYIAWTASOJW-UHFFFAOYSA-N 0.000 claims abstract 3
- 238000006243 chemical reaction Methods 0.000 claims description 39
- 241000244987 Daiswa polyphylla Species 0.000 claims description 26
- 230000014509 gene expression Effects 0.000 claims description 25
- 239000013598 vector Substances 0.000 claims description 23
- 241000894006 Bacteria Species 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 13
- 239000013604 expression vector Substances 0.000 claims description 12
- NFZYDZXHKFHPGA-QQHDHSITSA-N Chikusetsusaponin-V Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CCC(C[C@H]14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NFZYDZXHKFHPGA-QQHDHSITSA-N 0.000 claims description 9
- QDYPTQWAAOGCJD-UHFFFAOYSA-N Huzhangoside A Natural products OC1C(C)OC(OC2C(OCC(O)C2O)OC2C(C3C(C4C(C5(CCC6(CCC(C)(C)CC6C5=CC4)C(O)=O)C)(C)CC3)(C)CC2)(C)C)C(O)C1OC1OCC(O)C(O)C1O QDYPTQWAAOGCJD-UHFFFAOYSA-N 0.000 claims description 9
- NWMIYTWHUDFRPL-UHFFFAOYSA-N sapogenin Natural products COC(=O)C1(CO)C(O)CCC2(C)C1CCC3(C)C2CC=C4C5C(C)(O)C(C)CCC5(CCC34C)C(=O)O NWMIYTWHUDFRPL-UHFFFAOYSA-N 0.000 claims description 7
- WXMARHKAXWRNDM-GAMIEDRGSA-N diosgenin 3-O-beta-D-glucoside Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]([C@]1(OC[C@H](C)CC1)O5)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WXMARHKAXWRNDM-GAMIEDRGSA-N 0.000 claims description 6
- 239000002773 nucleotide Substances 0.000 claims description 6
- 125000003729 nucleotide group Chemical group 0.000 claims description 6
- WXMARHKAXWRNDM-UHFFFAOYSA-N (25R)-5alpha-spirost-5-en-3beta-ol 3-O-beta-D-galactopyranoside Natural products O1C2(OCC(C)CC2)C(C)C(C2(CCC3C4(C)CC5)C)C1CC2C3CC=C4CC5OC1OC(CO)C(O)C(O)C1O WXMARHKAXWRNDM-UHFFFAOYSA-N 0.000 claims description 5
- 239000001689 FEMA 4674 Substances 0.000 claims description 4
- 239000004384 Neotame Substances 0.000 claims description 4
- 229930182647 Trilobatin Natural products 0.000 claims description 4
- 230000009471 action Effects 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 4
- 108010070257 neotame Proteins 0.000 claims description 4
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 claims description 4
- 235000019412 neotame Nutrition 0.000 claims description 4
- 230000002194 synthesizing effect Effects 0.000 claims description 4
- GSTCPEBQYSOEHV-QNDFHXLGSA-N trilobatin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GSTCPEBQYSOEHV-QNDFHXLGSA-N 0.000 claims description 4
- 230000001939 inductive effect Effects 0.000 claims description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000006206 glycosylation reaction Methods 0.000 abstract description 15
- 230000013595 glycosylation Effects 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 10
- 230000037353 metabolic pathway Effects 0.000 abstract description 5
- 125000000539 amino acid group Chemical group 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 61
- 235000018102 proteins Nutrition 0.000 description 53
- 235000017709 saponins Nutrition 0.000 description 28
- 235000007319 Avena orientalis Nutrition 0.000 description 26
- 244000075850 Avena orientalis Species 0.000 description 26
- 210000004027 cell Anatomy 0.000 description 24
- 238000001179 sorption measurement Methods 0.000 description 24
- 239000007788 liquid Substances 0.000 description 23
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 108020004414 DNA Proteins 0.000 description 19
- 230000006698 induction Effects 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 238000001514 detection method Methods 0.000 description 14
- DRDCJEIZVLVWNC-SLBWPEPYSA-N UDP-beta-L-rhamnose Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 DRDCJEIZVLVWNC-SLBWPEPYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- 108700026244 Open Reading Frames Proteins 0.000 description 10
- 150000001413 amino acids Chemical group 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 239000006228 supernatant Substances 0.000 description 10
- 241000196324 Embryophyta Species 0.000 description 9
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 150000002500 ions Chemical class 0.000 description 8
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 238000000605 extraction Methods 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 230000009465 prokaryotic expression Effects 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 108010024636 Glutathione Proteins 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000003637 steroidlike Effects 0.000 description 5
- 150000003648 triterpenes Chemical class 0.000 description 5
- 239000002699 waste material Substances 0.000 description 5
- INLFWQCRAJUDCR-IQVMEADQSA-N (1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane] Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CCCCC4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 INLFWQCRAJUDCR-IQVMEADQSA-N 0.000 description 4
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 4
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 239000013599 cloning vector Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 229960003180 glutathione Drugs 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 3
- DZQMXBALGUHGJT-GUBZILKMSA-N Leu-Glu-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O DZQMXBALGUHGJT-GUBZILKMSA-N 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 108010049041 glutamylalanine Proteins 0.000 description 3
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Chemical compound NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 3
- 108010010147 glycylglutamine Proteins 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 230000001936 parietal effect Effects 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- FBFMBWCLBGQEBU-RXMALORBSA-N (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,5r,6s,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2s)-6-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecah Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FBFMBWCLBGQEBU-RXMALORBSA-N 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- 108050003820 2,3-oxidosqualene cyclases Proteins 0.000 description 2
- FBFMBWCLBGQEBU-GYMUUCMZSA-N 20-gluco-ginsenoside-Rf Natural products O([C@](CC/C=C(\C)/C)(C)[C@@H]1[C@H]2[C@H](O)C[C@H]3[C@](C)([C@]2(C)CC1)C[C@H](O[C@@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1C(C)(C)[C@@H](O)CC[C@]31C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FBFMBWCLBGQEBU-GYMUUCMZSA-N 0.000 description 2
- DKJPOZOEBONHFS-ZLUOBGJFSA-N Ala-Ala-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O DKJPOZOEBONHFS-ZLUOBGJFSA-N 0.000 description 2
- JNJHNBXBGNJESC-KKXDTOCCSA-N Ala-Tyr-Phe Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JNJHNBXBGNJESC-KKXDTOCCSA-N 0.000 description 2
- YJHKTAMKPGFJCT-NRPADANISA-N Ala-Val-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O YJHKTAMKPGFJCT-NRPADANISA-N 0.000 description 2
- KRXIWXCXOARFNT-ZLUOBGJFSA-N Asp-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O KRXIWXCXOARFNT-ZLUOBGJFSA-N 0.000 description 2
- QCVXMEHGFUMKCO-YUMQZZPRSA-N Asp-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O QCVXMEHGFUMKCO-YUMQZZPRSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000252229 Carassius auratus Species 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 108010076161 Cycloartenol synthase Proteins 0.000 description 2
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 description 2
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 description 2
- HYPFYJBWSTXDAS-UHFFFAOYSA-N Ginsenoside Rd Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C4CCC5C(C)(C)C(CCC5(C)C4CC(O)C23C)OC6OC(CO)C(O)C(O)C6OC7OC(CO)C(O)C(O)C7O)C HYPFYJBWSTXDAS-UHFFFAOYSA-N 0.000 description 2
- HYPVLWGNBIYTNA-GUBZILKMSA-N Gln-Leu-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HYPVLWGNBIYTNA-GUBZILKMSA-N 0.000 description 2
- OAGVHWYIBZMWLA-YFKPBYRVSA-N Glu-Gly-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)NCC(O)=O OAGVHWYIBZMWLA-YFKPBYRVSA-N 0.000 description 2
- SYOJVRNQCXYEOV-XVKPBYJWSA-N Gly-Val-Glu Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SYOJVRNQCXYEOV-XVKPBYJWSA-N 0.000 description 2
- 108010079364 N-glycylalanine Proteins 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 108010084592 Saporins Proteins 0.000 description 2
- 102000013530 TOR Serine-Threonine Kinases Human genes 0.000 description 2
- 108010065917 TOR Serine-Threonine Kinases Proteins 0.000 description 2
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 2
- YTPLVNUZZOBFFC-SCZZXKLOSA-N Val-Gly-Pro Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N1CCC[C@@H]1C(O)=O YTPLVNUZZOBFFC-SCZZXKLOSA-N 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 108010044940 alanylglutamine Proteins 0.000 description 2
- 108010047495 alanylglycine Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 230000004900 autophagic degradation Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000000667 effect on insulin Effects 0.000 description 2
- 238000011067 equilibration Methods 0.000 description 2
- 108010006664 gamma-glutamyl-glycyl-glycine Proteins 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000012215 gene cloning Methods 0.000 description 2
- FVIZARNDLVOMSU-IRFFNABBSA-N ginsenoside C-K Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FVIZARNDLVOMSU-IRFFNABBSA-N 0.000 description 2
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 2
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 2
- 108010037850 glycylvaline Proteins 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000033444 hydroxylation Effects 0.000 description 2
- 238000005805 hydroxylation reaction Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- PKGKOZOYXQMJNG-UHFFFAOYSA-N lupeol Natural products CC(=C)C1CC2C(C)(CCC3C4(C)CCC5C(C)(C)C(O)CCC5(C)C4CCC23C)C1 PKGKOZOYXQMJNG-UHFFFAOYSA-N 0.000 description 2
- MQYXUWHLBZFQQO-QGTGJCAVSA-N lupeol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-QGTGJCAVSA-N 0.000 description 2
- NELZMZLNTYWIPD-MLBSDYKWSA-N nuatigenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@](C)(CO)O1 NELZMZLNTYWIPD-MLBSDYKWSA-N 0.000 description 2
- IUCHKMAZAWJNBJ-RCYXVVTDSA-N oleanolic acid 3-O-beta-D-glucosiduronic acid Chemical compound O([C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CCC(C[C@H]14)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O IUCHKMAZAWJNBJ-RCYXVVTDSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 229940031439 squalene Drugs 0.000 description 2
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 229930002600 steroidal saponin Natural products 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- 229930182493 triterpene saponin Natural products 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- UOJAEODBOCLNBU-UHFFFAOYSA-N vinaginsenoside R4 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O UOJAEODBOCLNBU-UHFFFAOYSA-N 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- HDXIQHTUNGFJIC-UHFFFAOYSA-N (25R)-spirost-5-en-3beta-ol 3-O-<O-alpha-L-rhamnopyranosyl-(1-->2)-beta-D-glucopyranoside> Natural products O1C2(OCC(C)CC2)C(C)C(C2(CCC3C4(C)CC5)C)C1CC2C3CC=C4CC5OC1OC(CO)C(O)C(O)C1OC1OC(C)C(O)C(O)C1O HDXIQHTUNGFJIC-UHFFFAOYSA-N 0.000 description 1
- QYIMSPSDBYKPPY-RSKUXYSASA-N (S)-2,3-epoxysqualene Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CC[C@@H]1OC1(C)C QYIMSPSDBYKPPY-RSKUXYSASA-N 0.000 description 1
- -1 16,22 (S) -dihydroxycholesterol Chemical compound 0.000 description 1
- PPINMSZPTPRQQB-NHCYSSNCSA-N 2-[[(2s)-1-[(2s)-2-[[(2s)-2-amino-3-methylbutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]acetic acid Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O PPINMSZPTPRQQB-NHCYSSNCSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 101150090724 3 gene Proteins 0.000 description 1
- XZEUYTKSAYNYPK-UHFFFAOYSA-N 3beta-29-Norcycloart-24-en-3-ol Natural products C1CC2(C)C(C(CCC=C(C)C)C)CCC2(C)C2CCC3C(C)C(O)CCC33C21C3 XZEUYTKSAYNYPK-UHFFFAOYSA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- HHGYNJRJIINWAK-FXQIFTODSA-N Ala-Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HHGYNJRJIINWAK-FXQIFTODSA-N 0.000 description 1
- YLTKNGYYPIWKHZ-ACZMJKKPSA-N Ala-Ala-Glu Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O YLTKNGYYPIWKHZ-ACZMJKKPSA-N 0.000 description 1
- NHCPCLJZRSIDHS-ZLUOBGJFSA-N Ala-Asp-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O NHCPCLJZRSIDHS-ZLUOBGJFSA-N 0.000 description 1
- ZIWWTZWAKYBUOB-CIUDSAMLSA-N Ala-Asp-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O ZIWWTZWAKYBUOB-CIUDSAMLSA-N 0.000 description 1
- FUSPCLTUKXQREV-ACZMJKKPSA-N Ala-Glu-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O FUSPCLTUKXQREV-ACZMJKKPSA-N 0.000 description 1
- KXEVYGKATAMXJJ-ACZMJKKPSA-N Ala-Glu-Asp Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O KXEVYGKATAMXJJ-ACZMJKKPSA-N 0.000 description 1
- PAIHPOGPJVUFJY-WDSKDSINSA-N Ala-Glu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O PAIHPOGPJVUFJY-WDSKDSINSA-N 0.000 description 1
- ZVFVBBGVOILKPO-WHFBIAKZSA-N Ala-Gly-Ala Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O ZVFVBBGVOILKPO-WHFBIAKZSA-N 0.000 description 1
- MPLOSMWGDNJSEV-WHFBIAKZSA-N Ala-Gly-Asp Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MPLOSMWGDNJSEV-WHFBIAKZSA-N 0.000 description 1
- LMFXXZPPZDCPTA-ZKWXMUAHSA-N Ala-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N LMFXXZPPZDCPTA-ZKWXMUAHSA-N 0.000 description 1
- MQIGTEQXYCRLGK-BQBZGAKWSA-N Ala-Gly-Pro Chemical compound C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O MQIGTEQXYCRLGK-BQBZGAKWSA-N 0.000 description 1
- NYDBKUNVSALYPX-NAKRPEOUSA-N Ala-Ile-Arg Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NYDBKUNVSALYPX-NAKRPEOUSA-N 0.000 description 1
- TZDNWXDLYFIFPT-BJDJZHNGSA-N Ala-Ile-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O TZDNWXDLYFIFPT-BJDJZHNGSA-N 0.000 description 1
- VNYMOTCMNHJGTG-JBDRJPRFSA-N Ala-Ile-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O VNYMOTCMNHJGTG-JBDRJPRFSA-N 0.000 description 1
- MNZHHDPWDWQJCQ-YUMQZZPRSA-N Ala-Leu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O MNZHHDPWDWQJCQ-YUMQZZPRSA-N 0.000 description 1
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 1
- RGQCNKIDEQJEBT-CQDKDKBSSA-N Ala-Leu-Tyr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 RGQCNKIDEQJEBT-CQDKDKBSSA-N 0.000 description 1
- QUIGLPSHIFPEOV-CIUDSAMLSA-N Ala-Lys-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O QUIGLPSHIFPEOV-CIUDSAMLSA-N 0.000 description 1
- LDLSENBXQNDTPB-DCAQKATOSA-N Ala-Lys-Arg Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N LDLSENBXQNDTPB-DCAQKATOSA-N 0.000 description 1
- PMQXMXAASGFUDX-SRVKXCTJSA-N Ala-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCCN PMQXMXAASGFUDX-SRVKXCTJSA-N 0.000 description 1
- DWYROCSXOOMOEU-CIUDSAMLSA-N Ala-Met-Glu Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N DWYROCSXOOMOEU-CIUDSAMLSA-N 0.000 description 1
- DHBKYZYFEXXUAK-ONGXEEELSA-N Ala-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 DHBKYZYFEXXUAK-ONGXEEELSA-N 0.000 description 1
- ZBLQIYPCUWZSRZ-QEJZJMRPSA-N Ala-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 ZBLQIYPCUWZSRZ-QEJZJMRPSA-N 0.000 description 1
- IHMCQESUJVZTKW-UBHSHLNASA-N Ala-Phe-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 IHMCQESUJVZTKW-UBHSHLNASA-N 0.000 description 1
- OEVCHROQUIVQFZ-YTLHQDLWSA-N Ala-Thr-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](C)C(O)=O OEVCHROQUIVQFZ-YTLHQDLWSA-N 0.000 description 1
- CREYEAPXISDKSB-FQPOAREZSA-N Ala-Thr-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CREYEAPXISDKSB-FQPOAREZSA-N 0.000 description 1
- AETQNIIFKCMVHP-UVBJJODRSA-N Ala-Trp-Arg Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O AETQNIIFKCMVHP-UVBJJODRSA-N 0.000 description 1
- PGNNQOJOEGFAOR-KWQFWETISA-N Ala-Tyr-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=C(O)C=C1 PGNNQOJOEGFAOR-KWQFWETISA-N 0.000 description 1
- VHAQSYHSDKERBS-XPUUQOCRSA-N Ala-Val-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O VHAQSYHSDKERBS-XPUUQOCRSA-N 0.000 description 1
- SGYSTDWPNPKJPP-GUBZILKMSA-N Arg-Ala-Arg Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SGYSTDWPNPKJPP-GUBZILKMSA-N 0.000 description 1
- PEFFAAKJGBZBKL-NAKRPEOUSA-N Arg-Ala-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O PEFFAAKJGBZBKL-NAKRPEOUSA-N 0.000 description 1
- IASNWHAGGYTEKX-IUCAKERBSA-N Arg-Arg-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(O)=O IASNWHAGGYTEKX-IUCAKERBSA-N 0.000 description 1
- UISQLSIBJKEJSS-GUBZILKMSA-N Arg-Arg-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(O)=O UISQLSIBJKEJSS-GUBZILKMSA-N 0.000 description 1
- OQCWXQJLCDPRHV-UWVGGRQHSA-N Arg-Gly-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O OQCWXQJLCDPRHV-UWVGGRQHSA-N 0.000 description 1
- GNYUVVJYGJFKHN-RVMXOQNASA-N Arg-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N GNYUVVJYGJFKHN-RVMXOQNASA-N 0.000 description 1
- GMFAGHNRXPSSJS-SRVKXCTJSA-N Arg-Leu-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O GMFAGHNRXPSSJS-SRVKXCTJSA-N 0.000 description 1
- YBZMTKUDWXZLIX-UWVGGRQHSA-N Arg-Leu-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YBZMTKUDWXZLIX-UWVGGRQHSA-N 0.000 description 1
- BNYNOWJESJJIOI-XUXIUFHCSA-N Arg-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)N BNYNOWJESJJIOI-XUXIUFHCSA-N 0.000 description 1
- BTJVOUQWFXABOI-IHRRRGAJSA-N Arg-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(N)=N BTJVOUQWFXABOI-IHRRRGAJSA-N 0.000 description 1
- YFHATWYGAAXQCF-JYJNAYRXSA-N Arg-Pro-Phe Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YFHATWYGAAXQCF-JYJNAYRXSA-N 0.000 description 1
- VRTWYUYCJGNFES-CIUDSAMLSA-N Arg-Ser-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O VRTWYUYCJGNFES-CIUDSAMLSA-N 0.000 description 1
- PJOPLXOCKACMLK-KKUMJFAQSA-N Arg-Tyr-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O PJOPLXOCKACMLK-KKUMJFAQSA-N 0.000 description 1
- WOZDCBHUGJVJPL-AVGNSLFASA-N Arg-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N WOZDCBHUGJVJPL-AVGNSLFASA-N 0.000 description 1
- WIDVAWAQBRAKTI-YUMQZZPRSA-N Asn-Leu-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O WIDVAWAQBRAKTI-YUMQZZPRSA-N 0.000 description 1
- WLVLIYYBPPONRJ-GCJQMDKQSA-N Asn-Thr-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O WLVLIYYBPPONRJ-GCJQMDKQSA-N 0.000 description 1
- RGKKALNPOYURGE-ZKWXMUAHSA-N Asp-Ala-Val Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O RGKKALNPOYURGE-ZKWXMUAHSA-N 0.000 description 1
- VIRHEUMYXXLCBF-WDSKDSINSA-N Asp-Gly-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O VIRHEUMYXXLCBF-WDSKDSINSA-N 0.000 description 1
- OMMIEVATLAGRCK-BYPYZUCNSA-N Asp-Gly-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)NCC(O)=O OMMIEVATLAGRCK-BYPYZUCNSA-N 0.000 description 1
- YQKYLDVPCOGIRB-SEKJGCFDSA-N Asp-Leu-Thr-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O YQKYLDVPCOGIRB-SEKJGCFDSA-N 0.000 description 1
- QNMKWNONJGKJJC-NHCYSSNCSA-N Asp-Leu-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O QNMKWNONJGKJJC-NHCYSSNCSA-N 0.000 description 1
- LIVXPXUVXFRWNY-CIUDSAMLSA-N Asp-Lys-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O LIVXPXUVXFRWNY-CIUDSAMLSA-N 0.000 description 1
- DRCOAZZDQRCGGP-GHCJXIJMSA-N Asp-Ser-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DRCOAZZDQRCGGP-GHCJXIJMSA-N 0.000 description 1
- JSNWZMFSLIWAHS-HJGDQZAQSA-N Asp-Thr-Leu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O JSNWZMFSLIWAHS-HJGDQZAQSA-N 0.000 description 1
- XMKXONRMGJXCJV-LAEOZQHASA-N Asp-Val-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O XMKXONRMGJXCJV-LAEOZQHASA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 241000932522 Avena hispanica Species 0.000 description 1
- 235000002988 Avena strigosa Nutrition 0.000 description 1
- 241001678559 COVID-19 virus Species 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000222290 Cladosporium Species 0.000 description 1
- VNONINPVFQTJOC-RXEYMUOJSA-N Collettiside III Natural products O([C@@H]1[C@@H](O)[C@H](O[C@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@H](CO)O[C@@H]1O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]5[C@H](C)[C@@]6(O[C@H]5C4)OC[C@H](C)CC6)CC3)CC=2)CC1)[C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O1 VNONINPVFQTJOC-RXEYMUOJSA-N 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- 102000008178 Cyclin B1 Human genes 0.000 description 1
- 108010060385 Cyclin B1 Proteins 0.000 description 1
- RRTBTJPVUGMUNR-UHFFFAOYSA-N Cycloartanol Natural products C12CCC(C(C(O)CC3)(C)C)C3C2(CC)CCC2(C)C1(C)CCC2C(C)CCCC(C)C RRTBTJPVUGMUNR-UHFFFAOYSA-N 0.000 description 1
- SBMGKDLRJLYZCU-BIIVOSGPSA-N Cys-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)N)C(=O)O SBMGKDLRJLYZCU-BIIVOSGPSA-N 0.000 description 1
- SDXQKJAWASHMIZ-CIUDSAMLSA-N Cys-Glu-Met Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O SDXQKJAWASHMIZ-CIUDSAMLSA-N 0.000 description 1
- OHLLDUNVMPPUMD-DCAQKATOSA-N Cys-Leu-Val Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CS)N OHLLDUNVMPPUMD-DCAQKATOSA-N 0.000 description 1
- SWJYSDXMTPMBHO-FXQIFTODSA-N Cys-Pro-Ser Chemical compound [H]N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O SWJYSDXMTPMBHO-FXQIFTODSA-N 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 241001262815 Dactylogyrus Species 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- WUAYFMZULZDSLB-ACZMJKKPSA-N Gln-Ala-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O WUAYFMZULZDSLB-ACZMJKKPSA-N 0.000 description 1
- PONUFVLSGMQFAI-AVGNSLFASA-N Gln-Asn-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PONUFVLSGMQFAI-AVGNSLFASA-N 0.000 description 1
- BTSPOOHJBYJRKO-CIUDSAMLSA-N Gln-Asp-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O BTSPOOHJBYJRKO-CIUDSAMLSA-N 0.000 description 1
- LLRJEFPKIIBGJP-DCAQKATOSA-N Gln-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)N LLRJEFPKIIBGJP-DCAQKATOSA-N 0.000 description 1
- IKFZXRLDMYWNBU-YUMQZZPRSA-N Gln-Gly-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N IKFZXRLDMYWNBU-YUMQZZPRSA-N 0.000 description 1
- QBLMTCRYYTVUQY-GUBZILKMSA-N Gln-Leu-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O QBLMTCRYYTVUQY-GUBZILKMSA-N 0.000 description 1
- CAXXTYYGFYTBPV-IUCAKERBSA-N Gln-Leu-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CAXXTYYGFYTBPV-IUCAKERBSA-N 0.000 description 1
- WLRYGVYQFXRJDA-DCAQKATOSA-N Gln-Pro-Pro Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 WLRYGVYQFXRJDA-DCAQKATOSA-N 0.000 description 1
- PAOHIZNRJNIXQY-XQXXSGGOSA-N Gln-Thr-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O PAOHIZNRJNIXQY-XQXXSGGOSA-N 0.000 description 1
- JTWZNMUVQWWGOX-SOUVJXGZSA-N Gln-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCC(=O)N)N)C(=O)O JTWZNMUVQWWGOX-SOUVJXGZSA-N 0.000 description 1
- VYOILACOFPPNQH-UMNHJUIQSA-N Gln-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N VYOILACOFPPNQH-UMNHJUIQSA-N 0.000 description 1
- MXOODARRORARSU-ACZMJKKPSA-N Glu-Ala-Ser Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N MXOODARRORARSU-ACZMJKKPSA-N 0.000 description 1
- CGYDXNKRIMJMLV-GUBZILKMSA-N Glu-Arg-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O CGYDXNKRIMJMLV-GUBZILKMSA-N 0.000 description 1
- LTUVYLVIZHJCOQ-KKUMJFAQSA-N Glu-Arg-Phe Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LTUVYLVIZHJCOQ-KKUMJFAQSA-N 0.000 description 1
- DYFJZDDQPNIPAB-NHCYSSNCSA-N Glu-Arg-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O DYFJZDDQPNIPAB-NHCYSSNCSA-N 0.000 description 1
- YSPJWDABFLRKDK-QAETUUGQSA-N Glu-Gln-Gln-Tyr Chemical compound N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O YSPJWDABFLRKDK-QAETUUGQSA-N 0.000 description 1
- RFDHKPSHTXZKLL-IHRRRGAJSA-N Glu-Gln-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)O)N RFDHKPSHTXZKLL-IHRRRGAJSA-N 0.000 description 1
- XIKYNVKEUINBGL-IUCAKERBSA-N Glu-His-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)NCC(O)=O XIKYNVKEUINBGL-IUCAKERBSA-N 0.000 description 1
- ZHNHJYYFCGUZNQ-KBIXCLLPSA-N Glu-Ile-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O ZHNHJYYFCGUZNQ-KBIXCLLPSA-N 0.000 description 1
- DWBBKNPKDHXIAC-SRVKXCTJSA-N Glu-Leu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCC(O)=O DWBBKNPKDHXIAC-SRVKXCTJSA-N 0.000 description 1
- FBEJIDRSQCGFJI-GUBZILKMSA-N Glu-Leu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FBEJIDRSQCGFJI-GUBZILKMSA-N 0.000 description 1
- SWDNPSMMEWRNOH-HJGDQZAQSA-N Glu-Pro-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O SWDNPSMMEWRNOH-HJGDQZAQSA-N 0.000 description 1
- ARIORLIIMJACKZ-KKUMJFAQSA-N Glu-Pro-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ARIORLIIMJACKZ-KKUMJFAQSA-N 0.000 description 1
- RFTVTKBHDXCEEX-WDSKDSINSA-N Glu-Ser-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RFTVTKBHDXCEEX-WDSKDSINSA-N 0.000 description 1
- NTNUEBVGKMVANB-NHCYSSNCSA-N Glu-Val-Met Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCSC)C(O)=O NTNUEBVGKMVANB-NHCYSSNCSA-N 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- UGVQELHRNUDMAA-BYPYZUCNSA-N Gly-Ala-Gly Chemical compound [NH3+]CC(=O)N[C@@H](C)C(=O)NCC([O-])=O UGVQELHRNUDMAA-BYPYZUCNSA-N 0.000 description 1
- QPTNELDXWKRIFX-YFKPBYRVSA-N Gly-Gly-Gln Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O QPTNELDXWKRIFX-YFKPBYRVSA-N 0.000 description 1
- GDOZQTNZPCUARW-YFKPBYRVSA-N Gly-Gly-Glu Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O GDOZQTNZPCUARW-YFKPBYRVSA-N 0.000 description 1
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 1
- HMHRTKOWRUPPNU-RCOVLWMOSA-N Gly-Ile-Gly Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O HMHRTKOWRUPPNU-RCOVLWMOSA-N 0.000 description 1
- PAWIVEIWWYGBAM-YUMQZZPRSA-N Gly-Leu-Ala Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O PAWIVEIWWYGBAM-YUMQZZPRSA-N 0.000 description 1
- ULZCYBYDTUMHNF-IUCAKERBSA-N Gly-Leu-Glu Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O ULZCYBYDTUMHNF-IUCAKERBSA-N 0.000 description 1
- OQQKUTVULYLCDG-ONGXEEELSA-N Gly-Lys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(O)=O OQQKUTVULYLCDG-ONGXEEELSA-N 0.000 description 1
- YHYDTTUSJXGTQK-UWVGGRQHSA-N Gly-Met-Leu Chemical compound CSCC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(C)C)C(O)=O YHYDTTUSJXGTQK-UWVGGRQHSA-N 0.000 description 1
- FEUPVVCGQLNXNP-IRXDYDNUSA-N Gly-Phe-Phe Chemical compound C([C@H](NC(=O)CN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 FEUPVVCGQLNXNP-IRXDYDNUSA-N 0.000 description 1
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 1
- WCORRBXVISTKQL-WHFBIAKZSA-N Gly-Ser-Ser Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WCORRBXVISTKQL-WHFBIAKZSA-N 0.000 description 1
- RCHFYMASWAZQQZ-ZANVPECISA-N Gly-Trp-Ala Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CN)=CNC2=C1 RCHFYMASWAZQQZ-ZANVPECISA-N 0.000 description 1
- FBUMPXILDTWCJW-UHFFFAOYSA-N Gly-Trp-Ala-Pro Natural products C=1NC2=CC=CC=C2C=1CC(NC(=O)CN)C(=O)NC(C)C(=O)N1CCCC1C(O)=O FBUMPXILDTWCJW-UHFFFAOYSA-N 0.000 description 1
- JKSMZVCGQWVTBW-STQMWFEESA-N Gly-Trp-Asn Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(O)=O JKSMZVCGQWVTBW-STQMWFEESA-N 0.000 description 1
- GJHWILMUOANXTG-WPRPVWTQSA-N Gly-Val-Arg Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GJHWILMUOANXTG-WPRPVWTQSA-N 0.000 description 1
- YGHSQRJSHKYUJY-SCZZXKLOSA-N Gly-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN YGHSQRJSHKYUJY-SCZZXKLOSA-N 0.000 description 1
- IZVICCORZOSGPT-JSGCOSHPSA-N Gly-Val-Tyr Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O IZVICCORZOSGPT-JSGCOSHPSA-N 0.000 description 1
- AFPFGFUGETYOSY-HGNGGELXSA-N His-Ala-Glu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O AFPFGFUGETYOSY-HGNGGELXSA-N 0.000 description 1
- SVHKVHBPTOMLTO-DCAQKATOSA-N His-Arg-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O SVHKVHBPTOMLTO-DCAQKATOSA-N 0.000 description 1
- OHOXVDFVRDGFND-YUMQZZPRSA-N His-Cys-Gly Chemical compound N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CS)C(=O)NCC(O)=O OHOXVDFVRDGFND-YUMQZZPRSA-N 0.000 description 1
- ZVKDCQVQTGYBQT-LSJOCFKGSA-N His-Pro-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O ZVKDCQVQTGYBQT-LSJOCFKGSA-N 0.000 description 1
- UWSMZKRTOZEGDD-CUJWVEQBSA-N His-Thr-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O UWSMZKRTOZEGDD-CUJWVEQBSA-N 0.000 description 1
- XGBVLRJLHUVCNK-DCAQKATOSA-N His-Val-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O XGBVLRJLHUVCNK-DCAQKATOSA-N 0.000 description 1
- 101000600756 Homo sapiens 3-phosphoinositide-dependent protein kinase 1 Proteins 0.000 description 1
- 101001117146 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Proteins 0.000 description 1
- MKWSZEHGHSLNPF-NAKRPEOUSA-N Ile-Ala-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O)N MKWSZEHGHSLNPF-NAKRPEOUSA-N 0.000 description 1
- NYEYYMLUABXDMC-NHCYSSNCSA-N Ile-Gly-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)O)N NYEYYMLUABXDMC-NHCYSSNCSA-N 0.000 description 1
- NZGTYCMLUGYMCV-XUXIUFHCSA-N Ile-Lys-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N NZGTYCMLUGYMCV-XUXIUFHCSA-N 0.000 description 1
- ADDYYRVQQZFIMW-MNXVOIDGSA-N Ile-Lys-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ADDYYRVQQZFIMW-MNXVOIDGSA-N 0.000 description 1
- FFAUOCITXBMRBT-YTFOTSKYSA-N Ile-Lys-Ile Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FFAUOCITXBMRBT-YTFOTSKYSA-N 0.000 description 1
- SVZFKLBRCYCIIY-CYDGBPFRSA-N Ile-Pro-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SVZFKLBRCYCIIY-CYDGBPFRSA-N 0.000 description 1
- BATWGBRIZANGPN-ZPFDUUQYSA-N Ile-Pro-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)O)N BATWGBRIZANGPN-ZPFDUUQYSA-N 0.000 description 1
- PELCGFMHLZXWBQ-BJDJZHNGSA-N Ile-Ser-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)N PELCGFMHLZXWBQ-BJDJZHNGSA-N 0.000 description 1
- COWHUQXTSYTKQC-RWRJDSDZSA-N Ile-Thr-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N COWHUQXTSYTKQC-RWRJDSDZSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- HVXLSFNCWWWDPA-UHFFFAOYSA-N Isocycloartenol Natural products C1CC(O)C(C)(C)C2C31CC13CCC3(C)C(C(CCCC(C)=C)C)CCC3(C)C1CC2 HVXLSFNCWWWDPA-UHFFFAOYSA-N 0.000 description 1
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 1
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 1
- LHSGPCFBGJHPCY-UHFFFAOYSA-N L-leucine-L-tyrosine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LHSGPCFBGJHPCY-UHFFFAOYSA-N 0.000 description 1
- 108010059597 Lanosterol synthase Proteins 0.000 description 1
- KKXDHFKZWKLYGB-GUBZILKMSA-N Leu-Asn-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KKXDHFKZWKLYGB-GUBZILKMSA-N 0.000 description 1
- OIARJGNVARWKFP-YUMQZZPRSA-N Leu-Asn-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O OIARJGNVARWKFP-YUMQZZPRSA-N 0.000 description 1
- BPANDPNDMJHFEV-CIUDSAMLSA-N Leu-Asp-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O BPANDPNDMJHFEV-CIUDSAMLSA-N 0.000 description 1
- ILJREDZFPHTUIE-GUBZILKMSA-N Leu-Asp-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ILJREDZFPHTUIE-GUBZILKMSA-N 0.000 description 1
- NFHJQETXTSDZSI-DCAQKATOSA-N Leu-Cys-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NFHJQETXTSDZSI-DCAQKATOSA-N 0.000 description 1
- YORLGJINWYYIMX-KKUMJFAQSA-N Leu-Cys-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O YORLGJINWYYIMX-KKUMJFAQSA-N 0.000 description 1
- WIDZHJTYKYBLSR-DCAQKATOSA-N Leu-Glu-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WIDZHJTYKYBLSR-DCAQKATOSA-N 0.000 description 1
- ZFNLIDNJUWNIJL-WDCWCFNPSA-N Leu-Glu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZFNLIDNJUWNIJL-WDCWCFNPSA-N 0.000 description 1
- VBZOAGIPCULURB-QWRGUYRKSA-N Leu-Gly-His Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N VBZOAGIPCULURB-QWRGUYRKSA-N 0.000 description 1
- POZULHZYLPGXMR-ONGXEEELSA-N Leu-Gly-Val Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O POZULHZYLPGXMR-ONGXEEELSA-N 0.000 description 1
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 1
- BIZNDKMFQHDOIE-KKUMJFAQSA-N Leu-Phe-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(O)=O)CC1=CC=CC=C1 BIZNDKMFQHDOIE-KKUMJFAQSA-N 0.000 description 1
- WMIOEVKKYIMVKI-DCAQKATOSA-N Leu-Pro-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O WMIOEVKKYIMVKI-DCAQKATOSA-N 0.000 description 1
- QMKFDEUJGYNFMC-AVGNSLFASA-N Leu-Pro-Arg Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QMKFDEUJGYNFMC-AVGNSLFASA-N 0.000 description 1
- BMVFXOQHDQZAQU-DCAQKATOSA-N Leu-Pro-Asp Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)O)N BMVFXOQHDQZAQU-DCAQKATOSA-N 0.000 description 1
- VULJUQZPSOASBZ-SRVKXCTJSA-N Leu-Pro-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O VULJUQZPSOASBZ-SRVKXCTJSA-N 0.000 description 1
- XXXXOVFBXRERQL-ULQDDVLXSA-N Leu-Pro-Phe Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XXXXOVFBXRERQL-ULQDDVLXSA-N 0.000 description 1
- ADJWHHZETYAAAX-SRVKXCTJSA-N Leu-Ser-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N ADJWHHZETYAAAX-SRVKXCTJSA-N 0.000 description 1
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 1
- ZJZNLRVCZWUONM-JXUBOQSCSA-N Leu-Thr-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O ZJZNLRVCZWUONM-JXUBOQSCSA-N 0.000 description 1
- FBNPMTNBFFAMMH-AVGNSLFASA-N Leu-Val-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-AVGNSLFASA-N 0.000 description 1
- FBNPMTNBFFAMMH-UHFFFAOYSA-N Leu-Val-Arg Natural products CC(C)CC(N)C(=O)NC(C(C)C)C(=O)NC(C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-UHFFFAOYSA-N 0.000 description 1
- CGHXMODRYJISSK-NHCYSSNCSA-N Leu-Val-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O CGHXMODRYJISSK-NHCYSSNCSA-N 0.000 description 1
- FDBTVENULFNTAL-XQQFMLRXSA-N Leu-Val-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N FDBTVENULFNTAL-XQQFMLRXSA-N 0.000 description 1
- QESXLSQLQHHTIX-RHYQMDGZSA-N Leu-Val-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QESXLSQLQHHTIX-RHYQMDGZSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- 102100022119 Lipoprotein lipase Human genes 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- NFLFJGGKOHYZJF-BJDJZHNGSA-N Lys-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN NFLFJGGKOHYZJF-BJDJZHNGSA-N 0.000 description 1
- IZJGPPIGYTVXLB-FQUUOJAGSA-N Lys-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N IZJGPPIGYTVXLB-FQUUOJAGSA-N 0.000 description 1
- MYZMQWHPDAYKIE-SRVKXCTJSA-N Lys-Leu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O MYZMQWHPDAYKIE-SRVKXCTJSA-N 0.000 description 1
- ORVFEGYUJITPGI-IHRRRGAJSA-N Lys-Leu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN ORVFEGYUJITPGI-IHRRRGAJSA-N 0.000 description 1
- WGILOYIKJVQUPT-DCAQKATOSA-N Lys-Pro-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O WGILOYIKJVQUPT-DCAQKATOSA-N 0.000 description 1
- VWPJQIHBBOJWDN-DCAQKATOSA-N Lys-Val-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O VWPJQIHBBOJWDN-DCAQKATOSA-N 0.000 description 1
- 102000043136 MAP kinase family Human genes 0.000 description 1
- 108091054455 MAP kinase family Proteins 0.000 description 1
- ZAJNRWKGHWGPDQ-SDDRHHMPSA-N Met-Arg-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N ZAJNRWKGHWGPDQ-SDDRHHMPSA-N 0.000 description 1
- AEQVPPGEJJBFEE-CYDGBPFRSA-N Met-Ile-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O AEQVPPGEJJBFEE-CYDGBPFRSA-N 0.000 description 1
- JACMWNXOOUYXCD-JYJNAYRXSA-N Met-Val-Phe Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JACMWNXOOUYXCD-JYJNAYRXSA-N 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- WYBVBIHNJWOLCJ-UHFFFAOYSA-N N-L-arginyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCCN=C(N)N WYBVBIHNJWOLCJ-UHFFFAOYSA-N 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 1
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 1
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 1
- QYIMSPSDBYKPPY-UHFFFAOYSA-N OS Natural products CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC1OC1(C)C QYIMSPSDBYKPPY-UHFFFAOYSA-N 0.000 description 1
- 102000014160 PTEN Phosphohydrolase Human genes 0.000 description 1
- 108010011536 PTEN Phosphohydrolase Proteins 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- BKWJQWJPZMUWEG-LFSVMHDDSA-N Phe-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 BKWJQWJPZMUWEG-LFSVMHDDSA-N 0.000 description 1
- MGBRZXXGQBAULP-DRZSPHRISA-N Phe-Glu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 MGBRZXXGQBAULP-DRZSPHRISA-N 0.000 description 1
- BIYWZVCPZIFGPY-QWRGUYRKSA-N Phe-Gly-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CO)C(O)=O BIYWZVCPZIFGPY-QWRGUYRKSA-N 0.000 description 1
- CMHTUJQZQXFNTQ-OEAJRASXSA-N Phe-Leu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)N)O CMHTUJQZQXFNTQ-OEAJRASXSA-N 0.000 description 1
- VHDNDCPMHQMXIR-IHRRRGAJSA-N Phe-Met-Cys Chemical compound SC[C@@H](C(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC1=CC=CC=C1 VHDNDCPMHQMXIR-IHRRRGAJSA-N 0.000 description 1
- JLLJTMHNXQTMCK-UBHSHLNASA-N Phe-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC1=CC=CC=C1 JLLJTMHNXQTMCK-UBHSHLNASA-N 0.000 description 1
- WWPAHTZOWURIMR-ULQDDVLXSA-N Phe-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC1=CC=CC=C1 WWPAHTZOWURIMR-ULQDDVLXSA-N 0.000 description 1
- ZLAKUZDMKVKFAI-JYJNAYRXSA-N Phe-Pro-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O ZLAKUZDMKVKFAI-JYJNAYRXSA-N 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- HXQRIQXPGMPSRW-UHZRDUGNSA-N Pollinastanol Natural products O[C@@H]1C[C@H]2[C@@]3([C@]4([C@H]([C@@]5(C)[C@@](C)([C@H]([C@H](CCCC(C)C)C)CC5)CC4)CC2)C3)CC1 HXQRIQXPGMPSRW-UHZRDUGNSA-N 0.000 description 1
- DBALDZKOTNSBFM-FXQIFTODSA-N Pro-Ala-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O DBALDZKOTNSBFM-FXQIFTODSA-N 0.000 description 1
- UAYHMOIGIQZLFR-NHCYSSNCSA-N Pro-Gln-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O UAYHMOIGIQZLFR-NHCYSSNCSA-N 0.000 description 1
- NMELOOXSGDRBRU-YUMQZZPRSA-N Pro-Glu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1 NMELOOXSGDRBRU-YUMQZZPRSA-N 0.000 description 1
- WVOXLKUUVCCCSU-ZPFDUUQYSA-N Pro-Glu-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WVOXLKUUVCCCSU-ZPFDUUQYSA-N 0.000 description 1
- HAAQQNHQZBOWFO-LURJTMIESA-N Pro-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H]1CCCN1 HAAQQNHQZBOWFO-LURJTMIESA-N 0.000 description 1
- XQHGISDMVBTGAL-ULQDDVLXSA-N Pro-His-Phe Chemical compound C([C@@H](C(=O)[O-])NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1[NH2+]CCC1)C1=CC=CC=C1 XQHGISDMVBTGAL-ULQDDVLXSA-N 0.000 description 1
- KDBHVPXBQADZKY-GUBZILKMSA-N Pro-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KDBHVPXBQADZKY-GUBZILKMSA-N 0.000 description 1
- FHZJRBVMLGOHBX-GUBZILKMSA-N Pro-Pro-Asp Chemical compound OC(=O)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1)C(O)=O FHZJRBVMLGOHBX-GUBZILKMSA-N 0.000 description 1
- POQFNPILEQEODH-FXQIFTODSA-N Pro-Ser-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O POQFNPILEQEODH-FXQIFTODSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- WTUJZHKANPDPIN-CIUDSAMLSA-N Ser-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N WTUJZHKANPDPIN-CIUDSAMLSA-N 0.000 description 1
- QVOGDCQNGLBNCR-FXQIFTODSA-N Ser-Arg-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O QVOGDCQNGLBNCR-FXQIFTODSA-N 0.000 description 1
- KNZQGAUEYZJUSQ-ZLUOBGJFSA-N Ser-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N KNZQGAUEYZJUSQ-ZLUOBGJFSA-N 0.000 description 1
- WSTIOCFMWXNOCX-YUMQZZPRSA-N Ser-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CO)N WSTIOCFMWXNOCX-YUMQZZPRSA-N 0.000 description 1
- XXXAXOWMBOKTRN-XPUUQOCRSA-N Ser-Gly-Val Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXXAXOWMBOKTRN-XPUUQOCRSA-N 0.000 description 1
- UGHCUDLCCVVIJR-VGDYDELISA-N Ser-His-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CO)N UGHCUDLCCVVIJR-VGDYDELISA-N 0.000 description 1
- CICQXRWZNVXFCU-SRVKXCTJSA-N Ser-His-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O CICQXRWZNVXFCU-SRVKXCTJSA-N 0.000 description 1
- CAOYHZOWXFFAIR-CIUDSAMLSA-N Ser-His-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O CAOYHZOWXFFAIR-CIUDSAMLSA-N 0.000 description 1
- LRZLZIUXQBIWTB-KATARQTJSA-N Ser-Lys-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LRZLZIUXQBIWTB-KATARQTJSA-N 0.000 description 1
- JAWGSPUJAXYXJA-IHRRRGAJSA-N Ser-Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)N)CC1=CC=CC=C1 JAWGSPUJAXYXJA-IHRRRGAJSA-N 0.000 description 1
- FLMYSKVSDVHLEW-SVSWQMSJSA-N Ser-Thr-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FLMYSKVSDVHLEW-SVSWQMSJSA-N 0.000 description 1
- FZNNGIHSIPKFRE-QEJZJMRPSA-N Ser-Trp-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(N)=O)C(O)=O FZNNGIHSIPKFRE-QEJZJMRPSA-N 0.000 description 1
- JZRYFUGREMECBH-XPUUQOCRSA-N Ser-Val-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O JZRYFUGREMECBH-XPUUQOCRSA-N 0.000 description 1
- YEDSOSIKVUMIJE-DCAQKATOSA-N Ser-Val-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O YEDSOSIKVUMIJE-DCAQKATOSA-N 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- BSNZTJXVDOINSR-JXUBOQSCSA-N Thr-Ala-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BSNZTJXVDOINSR-JXUBOQSCSA-N 0.000 description 1
- LVHHEVGYAZGXDE-KDXUFGMBSA-N Thr-Ala-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)N1CCC[C@@H]1C(=O)O)N)O LVHHEVGYAZGXDE-KDXUFGMBSA-N 0.000 description 1
- DWYAUVCQDTZIJI-VZFHVOOUSA-N Thr-Ala-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O DWYAUVCQDTZIJI-VZFHVOOUSA-N 0.000 description 1
- DHPPWTOLRWYIDS-XKBZYTNZSA-N Thr-Cys-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(O)=O DHPPWTOLRWYIDS-XKBZYTNZSA-N 0.000 description 1
- OYTNZCBFDXGQGE-XQXXSGGOSA-N Thr-Gln-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)O)N)O OYTNZCBFDXGQGE-XQXXSGGOSA-N 0.000 description 1
- LHEZGZQRLDBSRR-WDCWCFNPSA-N Thr-Glu-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LHEZGZQRLDBSRR-WDCWCFNPSA-N 0.000 description 1
- HEJJDUDEHLPDAW-CUJWVEQBSA-N Thr-His-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CS)C(=O)O)N)O HEJJDUDEHLPDAW-CUJWVEQBSA-N 0.000 description 1
- YUPVPKZBKCLFLT-QTKMDUPCSA-N Thr-His-Val Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](C(C)C)C(=O)O)N)O YUPVPKZBKCLFLT-QTKMDUPCSA-N 0.000 description 1
- OHDXOXIZXSFCDN-RCWTZXSCSA-N Thr-Met-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OHDXOXIZXSFCDN-RCWTZXSCSA-N 0.000 description 1
- VTMGKRABARCZAX-OSUNSFLBSA-N Thr-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O VTMGKRABARCZAX-OSUNSFLBSA-N 0.000 description 1
- COYHRQWNJDJCNA-NUJDXYNKSA-N Thr-Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O COYHRQWNJDJCNA-NUJDXYNKSA-N 0.000 description 1
- FBQHKSPOIAFUEI-OWLDWWDNSA-N Thr-Trp-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(O)=O FBQHKSPOIAFUEI-OWLDWWDNSA-N 0.000 description 1
- VZBWRZGNEPBRDE-HZUKXOBISA-N Trp-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N VZBWRZGNEPBRDE-HZUKXOBISA-N 0.000 description 1
- NXAPHBHZCMQORW-FDARSICLSA-N Trp-Arg-Ile Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NXAPHBHZCMQORW-FDARSICLSA-N 0.000 description 1
- UKINEYBQXPMOJO-UBHSHLNASA-N Trp-Asn-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N UKINEYBQXPMOJO-UBHSHLNASA-N 0.000 description 1
- IVBJBFSWJDNQFW-XIRDDKMYSA-N Trp-Pro-Glu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O IVBJBFSWJDNQFW-XIRDDKMYSA-N 0.000 description 1
- IKUMWSDCGQVGHC-UMPQAUOISA-N Trp-Pro-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC2=CNC3=CC=CC=C32)N)O IKUMWSDCGQVGHC-UMPQAUOISA-N 0.000 description 1
- HTGJDTPQYFMKNC-VFAJRCTISA-N Trp-Thr-Leu Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)[C@@H](C)O)=CNC2=C1 HTGJDTPQYFMKNC-VFAJRCTISA-N 0.000 description 1
- MXKUGFHWYYKVDV-SZMVWBNQSA-N Trp-Val-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(C)C)C(O)=O MXKUGFHWYYKVDV-SZMVWBNQSA-N 0.000 description 1
- DXYWRYQRKPIGGU-BPNCWPANSA-N Tyr-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 DXYWRYQRKPIGGU-BPNCWPANSA-N 0.000 description 1
- NRFTYDWKWGJLAR-MELADBBJSA-N Tyr-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)O NRFTYDWKWGJLAR-MELADBBJSA-N 0.000 description 1
- QSFJHIRIHOJRKS-ULQDDVLXSA-N Tyr-Leu-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QSFJHIRIHOJRKS-ULQDDVLXSA-N 0.000 description 1
- RVGVIWNHABGIFH-IHRRRGAJSA-N Tyr-Val-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O RVGVIWNHABGIFH-IHRRRGAJSA-N 0.000 description 1
- DDRBQONWVBDQOY-GUBZILKMSA-N Val-Ala-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O DDRBQONWVBDQOY-GUBZILKMSA-N 0.000 description 1
- AUMNPAUHKUNHHN-BYULHYEWSA-N Val-Asn-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N AUMNPAUHKUNHHN-BYULHYEWSA-N 0.000 description 1
- VUTHNLMCXKLLFI-LAEOZQHASA-N Val-Asp-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N VUTHNLMCXKLLFI-LAEOZQHASA-N 0.000 description 1
- KOPBYUSPXBQIHD-NRPADANISA-N Val-Cys-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KOPBYUSPXBQIHD-NRPADANISA-N 0.000 description 1
- PWRITNSESKQTPW-NRPADANISA-N Val-Gln-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N PWRITNSESKQTPW-NRPADANISA-N 0.000 description 1
- UZDHNIJRRTUKKC-DLOVCJGASA-N Val-Gln-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N UZDHNIJRRTUKKC-DLOVCJGASA-N 0.000 description 1
- GBESYURLQOYWLU-LAEOZQHASA-N Val-Glu-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N GBESYURLQOYWLU-LAEOZQHASA-N 0.000 description 1
- VVZDBPBZHLQPPB-XVKPBYJWSA-N Val-Glu-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O VVZDBPBZHLQPPB-XVKPBYJWSA-N 0.000 description 1
- PIFJAFRUVWZRKR-QMMMGPOBSA-N Val-Gly-Gly Chemical compound CC(C)[C@H]([NH3+])C(=O)NCC(=O)NCC([O-])=O PIFJAFRUVWZRKR-QMMMGPOBSA-N 0.000 description 1
- OPGWZDIYEYJVRX-AVGNSLFASA-N Val-His-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N OPGWZDIYEYJVRX-AVGNSLFASA-N 0.000 description 1
- SBJCTAZFSZXWSR-AVGNSLFASA-N Val-Met-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N SBJCTAZFSZXWSR-AVGNSLFASA-N 0.000 description 1
- SJRUJQFQVLMZFW-WPRPVWTQSA-N Val-Pro-Gly Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O SJRUJQFQVLMZFW-WPRPVWTQSA-N 0.000 description 1
- USLVEJAHTBLSIL-CYDGBPFRSA-N Val-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C USLVEJAHTBLSIL-CYDGBPFRSA-N 0.000 description 1
- DOFAQXCYFQKSHT-SRVKXCTJSA-N Val-Pro-Pro Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DOFAQXCYFQKSHT-SRVKXCTJSA-N 0.000 description 1
- SDHZOOIGIUEPDY-JYJNAYRXSA-N Val-Ser-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](N)C(C)C)C(O)=O)=CNC2=C1 SDHZOOIGIUEPDY-JYJNAYRXSA-N 0.000 description 1
- UVHFONIHVHLDDQ-IFFSRLJSSA-N Val-Thr-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O UVHFONIHVHLDDQ-IFFSRLJSSA-N 0.000 description 1
- JAIZPWVHPQRYOU-ZJDVBMNYSA-N Val-Thr-Thr Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O JAIZPWVHPQRYOU-ZJDVBMNYSA-N 0.000 description 1
- IRAUYEAFPFPVND-UVBJJODRSA-N Val-Trp-Ala Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](C)C(O)=O)=CNC2=C1 IRAUYEAFPFPVND-UVBJJODRSA-N 0.000 description 1
- 102100024148 [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Human genes 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 108010008685 alanyl-glutamyl-aspartic acid Proteins 0.000 description 1
- 108010078114 alanyl-tryptophyl-alanine Proteins 0.000 description 1
- 108010041407 alanylaspartic acid Proteins 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 1
- FSLPMRQHCOLESF-SFMCKYFRSA-N alpha-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C FSLPMRQHCOLESF-SFMCKYFRSA-N 0.000 description 1
- SJMCNAVDHDBMLL-UHFFFAOYSA-N alpha-amyrin Natural products CC1CCC2(C)CCC3(C)C(=CCC4C5(C)CCC(O)CC5CCC34C)C2C1C SJMCNAVDHDBMLL-UHFFFAOYSA-N 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 108010008355 arginyl-glutamine Proteins 0.000 description 1
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 1
- 108010029539 arginyl-prolyl-proline Proteins 0.000 description 1
- 108010068380 arginylarginine Proteins 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 108010068265 aspartyltyrosine Proteins 0.000 description 1
- 238000012098 association analyses Methods 0.000 description 1
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 1
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 1
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 1
- 108010020595 beta-casomorphin 4 Proteins 0.000 description 1
- 239000012148 binding buffer Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000025084 cell cycle arrest Effects 0.000 description 1
- 230000004186 co-expression Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- ONQRKEUAIJMULO-YBXTVTTCSA-N cycloartenol Chemical compound CC(C)([C@@H](O)CC1)[C@H]2[C@@]31C[C@@]13CC[C@]3(C)[C@@H]([C@@H](CCC=C(C)C)C)CC[C@@]3(C)[C@@H]1CC2 ONQRKEUAIJMULO-YBXTVTTCSA-N 0.000 description 1
- YNBJLDSWFGUFRT-UHFFFAOYSA-N cycloartenol Natural products CC(CCC=C(C)C)C1CCC2(C)C1(C)CCC34CC35CCC(O)C(C)(C)C5CCC24C YNBJLDSWFGUFRT-UHFFFAOYSA-N 0.000 description 1
- FODTZLFLDFKIQH-UHFFFAOYSA-N cycloartenol trans-ferulate Natural products C1=C(O)C(OC)=CC(C=CC(=O)OC2C(C3CCC4C5(C)CCC(C5(C)CCC54CC53CC2)C(C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-UHFFFAOYSA-N 0.000 description 1
- 108010016616 cysteinylglycine Proteins 0.000 description 1
- 108010060199 cysteinylproline Proteins 0.000 description 1
- OORMXZNMRWBSTK-LGFJJATJSA-N dammarane Chemical compound C1CCC(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@H](C)CCCC(C)C)[C@H]4CC[C@@H]3[C@]21C OORMXZNMRWBSTK-LGFJJATJSA-N 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- VNONINPVFQTJOC-ZGXDEBHDSA-N dioscin Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H](O)[C@@H](O)[C@H](C)O1)O)O[C@@H]1CC2=CC[C@H]3[C@@H]4C[C@H]5[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@@H]([C@]1(OC[C@H](C)CC1)O5)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O VNONINPVFQTJOC-ZGXDEBHDSA-N 0.000 description 1
- CJNUQCDDINHHHD-APRUHSSNSA-N dioscin Natural products C[C@@H]1CC[C@@]2(OC1)O[C@H]3C[C@H]4[C@@H]5CC=C6C[C@H](CC[C@@H]6[C@H]5CC[C@]4(C)[C@H]3[C@@H]2C)O[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O[C@@H]9O[C@@H](C)[C@H](O)[C@@H](O)[C@H]9O CJNUQCDDINHHHD-APRUHSSNSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000002222 downregulating effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 108010080575 glutamyl-aspartyl-alanine Proteins 0.000 description 1
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 108010075431 glycyl-alanyl-phenylalanine Proteins 0.000 description 1
- 108010027668 glycyl-alanyl-valine Proteins 0.000 description 1
- 108010001064 glycyl-glycyl-glycyl-glycine Proteins 0.000 description 1
- 108010066198 glycyl-leucyl-phenylalanine Proteins 0.000 description 1
- 108010079413 glycyl-prolyl-glutamic acid Proteins 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010081551 glycylphenylalanine Proteins 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 108010012058 leucyltyrosine Proteins 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 1
- 108010044348 lysyl-glutamyl-aspartic acid Proteins 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
- NELZMZLNTYWIPD-FTFHAVOMSA-N nuatigenin Natural products OC[C@@]1(C)O[C@]2([C@H](C)[C@@H]3[C@]4(C)[C@H]([C@H]5[C@@H]([C@]6(C)C(=CC5)C[C@@H](O)CC6)CC4)C[C@@H]3O2)CC1 NELZMZLNTYWIPD-FTFHAVOMSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 229940038580 oat bran Drugs 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 108010012581 phenylalanylglutamate Proteins 0.000 description 1
- 108010083476 phenylalanyltryptophan Proteins 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- VNONINPVFQTJOC-UHFFFAOYSA-N polyphyllin III Natural products O1C2(OCC(C)CC2)C(C)C(C2(CCC3C4(C)CC5)C)C1CC2C3CC=C4CC5OC(C(C1O)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C1OC1OC(C)C(O)C(O)C1O VNONINPVFQTJOC-UHFFFAOYSA-N 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108010031719 prolyl-serine Proteins 0.000 description 1
- 108010090894 prolylleucine Proteins 0.000 description 1
- 108010053725 prolylvaline Proteins 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- QEVHRUUCFGRFIF-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C(C5=CC=C(OC)C=C5N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 QEVHRUUCFGRFIF-MDEJGZGSSA-N 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 108010080629 tryptophan-leucine Proteins 0.000 description 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
- 108010017949 tyrosyl-glycyl-glycine Proteins 0.000 description 1
- 108010072644 valyl-alanyl-prolyl-glycine Proteins 0.000 description 1
- 108010015385 valyl-prolyl-proline Proteins 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1051—Hexosyltransferases (2.4.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
- C12P33/20—Preparation of steroids containing heterocyclic rings
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention relates to a saponin metabolic pathway, in particular to oat glycosyltransferase AsUGT73E5 and application thereof in steroid saponin synthesis. The glycosyltransferase provided by the invention is protein as described in the following a1 or a 2: a1. a protein with an amino acid sequence shown as SEQ ID NO. 1; a2. and (3) a protein with glycosyltransferase activity, which is formed by substituting and/or deleting and/or adding one or more amino acid residues in the amino acid sequence shown in SEQ ID NO. 1. The glycosyltransferase can take diosgenin, pennogenin or neoacteoside as a substrate to generate corresponding glycosylation products in the presence of UDP-Glc.
Description
Technical Field
The invention relates to a saponin metabolic pathway, in particular to oat glycosyltransferase AsUGT73E5 and application thereof in steroid saponin synthesis.
Background
The paris polyphylla is a general term of plants in paris of the family lily, can be used as a main raw material of Chinese patent medicines such as Yunnan white drug powder, gongxuening, heat toxin clearing and the like, and has extremely high medicinal and economic values. Steroid saponins are the main chemical components of Paris polyphylla plants, 160 species have been identified at present, and mainly comprise Paris polyphylla saponins (polyphelin) I, II, III, V (dioscin) and VI, VII (pennogenin), and the pharmacological activity is wide. Antitumor is the main effect of paris saponin, paris saponin I induces autophagy and cell cycle arrest by inhibiting PDK1/Akt/mTOR signaling pathway in human gastric cancer HGC-27 cells and down regulating cyclin B1 (He et al 2019). Paris polyphylla VI induces apoptosis and autophagy in non-small cell lung cancer via ROS-triggered mTOR signaling pathway (Teng et al 2019). Paris polyphylla saponin VII can promote mitochondria to generate ROS and activate MAPK and PTEN/p53 pathways, and jointly induce apoptosis of HepG2 human liver cancer cells (Zhang et al 2016). The paris polyphylla saponin VII has good effect in resisting bacteria and diminishing inflammation, can remarkably inhibit the growth of dendritic cladosporium, candida and propionibacterium acnes, and can be used as an effective substitute for synthetic medicines (Deng et al 2008; qin et al 2012). Diosgenin (diogenin) can enhance lipoprotein lipase, liver lipase, superoxide dismutase, and cereal of hyperlipidemic miceThe activities of the glutathione peroxidase and the nitric oxide synthase improve the lipid distribution and play a role in reducing blood fat (Gong et al 2010). Paris polyphylla saponin III has excellent insect repellent activity, and can kill dactylogyrus (EC) parasitizing in gill part of goldfish 50 =18.06mg l -1 ) And is low toxic to goldfish (Wang et al 2010). In the new coronapneumonia study, the saponin molecules were found to have potential anti-new coronavirus activity. By docking screening, it is speculated that paris saponin I binds to 2019-nCoV major protease (M protease) and prevents viral replication (Yan et al 2020).
The research of paris polyphylla saponin at the present stage mainly focuses on medicine and clinic, so that the understanding of metabolic pathways, especially downstream biosynthesis processes, is quite lacking. 2,3-oxidosqualene (2, 3-oxadiquatene) is a common precursor for sterol and triterpene synthesis, and a sterols or triterpene skeleton is produced under the catalysis of 2,3-oxidosqualene cyclase (2, 3-Oxidosqualene cyclases, OSCs). Most pentacyclic triterpene synthases are capable of catalyzing the formation of a dammarane type cation in the "hair-hair" conformation from 2, 3-oxidized squalene, followed by further rearrangement to yield pentacyclic triterpenes such as α -amyrin, β -amyrin, lupeol (lupeol) (Xue et al 2018). Cycloartenol synthase (cycloartenol synthase) catalyzes the formation of a presteroid cation in a "pair-coat-pair" conformation from 2, 3-oxidized squalene, followed by conversion to cycloartenol, and synthesis of cholesterol through a series of reactions. The cholesterol content in plants, although generally low, is an important component of plant sterols (phytosterol) and is also a direct precursor of steroidal saponins (C. Rdenas et al 2015). The synthesis of steroidal sapogenins requires hydroxylation of cholesterol side chains, and is mainly modified by cytochrome P450 enzymes (CYPs). For example, CYP90Bs are found in Paris polyphylla (Paris polyphella) to evolve sterol polyhydroxyenzyme activity by gene replication, ppCYP90G4 can catalyze hydroxylation of cholesterol at C16 and C22 with E ring closure. 16,22 (S) -dihydroxycholesterol is further hydroxylated at position C26 to form diosgenin (Christ et al 2019) under the action of PpCYP94D108 and other enzymes, while pennogenin (pennogenin) at position C17P 450 enzyme remains to be resolved. Finally, diosgenin or pennogenin is glycosylated under the action of glycosyltransferase (UDP-glycosyltransferase, UGT) to form rhizoma paridis saponin with various biological activities. Currently, there are few reports on the study of glycosylation modification of steroidal sapogenins.
The paris polyphylla saponin is basically derived from plant extraction, however, due to excessive development, the resources of paris polyphylla are exhausted. The use of synthetic biology to construct heterologous biosynthetic pathways is becoming an effective way to obtain natural active ingredients. However, the paris plant has huge genome and numerous saponins, and it is difficult to analyze the metabolic pathway of paris saponins through the gene co-expression network. Oat (Avena sativa l.) is the only saponin-rich plant in the grasses (Vincken et al 2007) and two different types of saponins can be synthesized. One is the triterpene saponin-avenacins (avenacins) synthesized in the root and root tip, and the other is the steroid saponin-avenacins (avenacins) accumulated in leaves and grains. Oat is annual herb, has short growth cycle, can complete one growth cycle under long sunlight condition for 3-4 months, and can be used as an ideal mode material for researching the synthesis path of steroid saponin. With the discovery of the triterpene saponin avenacins metabolic gene cluster, the synthesis way of oat triterpene saponin has been completely analyzed through many years of research (Louveau et al 2018; orme et al 2019).
Disclosure of Invention
In order to analyze the metabolic pathway of the paris polyphylla saponin and realize the artificial synthesis of the paris polyphylla saponin, two oat glycosyltransferases which are respectively named as AsUGT73E5 and AsUGT73E1 are obtained by taking oat as a mode material. To verify glycosyltransferase function, we designed PCR primers for coding regions of glycosyltransferase genes AsUGT73E5 and AsUGT73E1, asUGT73E5-ORF-F/R, asUGT E1-ORF-F/R. PCR amplification is carried out by taking the oat seedling cDNA after reverse transcription as a template, and the AsUGT73E5 and AsUGT73E1 genes are obtained. The open reading frame of the AsUGT73E5 gene contains 1548 bases, the nucleotide sequence of the gene is shown as SEQ ID NO. 2, and the coded amino acid sequence is shown as SEQ ID NO. 1. The open reading frame of the AsUGT73E1 gene contains 1473 bases, the nucleotide sequence of the AsUGT73E1 gene is shown as SEQ ID NO. 4, and the coded amino acid sequence of the AsUGT73E1 gene is shown as SEQ ID NO. 3.
Then, we performed protein expression and purification. The Open Reading Frames (ORFs) of the genes AsUGT73E5 and AsUGT73E1 are cloned into a prokaryotic expression vector pGEX-6p-1 by homologous recombination, and expression competent Rosetta (DE 3) is transformed. Cultivated in Amp-resistant LB liquid medium to od600=0.6, and induced overnight at low temperature with addition of IPTG. After the cells were sonicated, proteins in the supernatant were purified by Glutathione Beads, and each fraction was collected for SDS-PAGE analysis (FIG. 2). The recombinant proteins all appeared to have a distinct band around 80kDa compared to the uninduced control samples. The AsUGT73E5 and AsUGT73E1 proteins respectively comprise 515 and 490 amino acids, and the molecular weights of the fused AsUGT73E5 and AsUGT73E1 proteins are 82.21KDa and 79.79KDa respectively.
Next, we used diosgenin, pennogenin and neoacteoside to perform functional verification on glycosyltransferases AsUGT73E5 and AsUGT73E1, respectively, with the following results:
HPLC detection is carried out on the product of the reaction of AsUGT73E5 protein, diosgenin and UDP-Glc (figure 3), and compared with the no-load reaction, the product of AsUGT73E5 shows a new peak (product 1) at 22.3min, and the peak outlet time is the same as that of a trillin standard product. The sample was recovered, and the reaction was continued by adding AsUGT73E1 protein and UDP-Rha, and a new product peak (product 2) was observed at 20.7min, which time was consistent with the rhizoma paridis saponin V standard. TOF positive ion scanning mode detection is shown in FIG. 4, the molecular weights of product 1 and product 2 are 577.38 (M+H+) and 723.43 (M+H+), respectively, and are consistent with those of trilobatin (576.3) and parietal saporin V (722.4), which shows that parietal sapogenin is continuously catalyzed by AsUGT73E5 and AsUGT73E1 to generate parietal saporin V.
After HPLC detection of the product of the reaction of AsUGT73E5 protein with pennogenin, UDP-Glc (FIG. 5), the product of AsUGT73E5 showed a new peak at 18.8min (product 3) compared with the empty reaction. The sample was recovered, and the reaction was continued by adding AsUGT73E1 protein and UDP-Rha, and a new product peak (product 4) was observed at 17.1min, which time was consistent with the Paris polyphylla saponin VI standard. TOF positive ion scanning mode detection is shown in FIG. 6, the molecular weights of product 3 and product 4 are 593.37 (M+H+) and 739.43 (M+H+), respectively, and are consistent with the molecular weights of pennogenin-3-O-glucoside (592.3) and parisonin VI (738.4), which indicates that pennogenin is continuously catalyzed by AsUGT73E5 and AsUGT73E1 to generate parisonin VI.
After HPLC detection of the product of the reaction of AsUGT73E5 protein with neoacteosin, UDP-Glc (FIG. 8), the product of AsUGT73E5 showed a new peak at 16.7min (product 5) compared to the empty reaction. The sample was recovered and the reaction was continued by adding AsUGT73E1 protein and UDP-Rha, and a second product peak (product 6) was present at 15.6 min. TOF positive ion scanning mode detection is shown in FIG. 9, the molecular weights of product 5 and product 6 are 593.37 (M+H) + ) And 739.43 (M+H) + ) Indicating that the neotame sapogenin generates corresponding glycosylation products after being continuously catalyzed by AsUGT73E5 and AsUGT73E1.
Based on the above studies, the present invention provides a glycosyltransferase which is a protein as described in a1 or a2 below:
a1. a protein with an amino acid sequence shown as SEQ ID NO. 1;
a2. and (3) a protein with glycosyltransferase activity, which is formed by substituting and/or deleting and/or adding one or more amino acid residues in the amino acid sequence shown in SEQ ID NO. 1.
Genes encoding the glycosyltransferases are also within the scope of the invention.
In some embodiments of the invention, the nucleotide sequence of the gene is shown in SEQ ID NO. 2.
Expression cassettes, vectors or recombinant bacteria containing said genes are also within the scope of the invention.
In some embodiments, the vector is a cloning vector comprising the gene encoding the glycosyltransferase and elements required for plasmid replication, e.g., pClone007 Blunt Simple Vector into which the encoding gene is inserted. In other embodiments, the vector is an expression vector comprising a gene encoding the glycosyltransferase and an element capable of successful protein expression, e.g., pGEX-6p-1 vector into which the encoding gene is inserted.
In some embodiments, the recombinant bacterium is a recombinant bacterium comprising a cloning vector, such as e.coli DH5 a, and the gene encoding the glycosyltransferase is replicated by culturing the recombinant bacterium. In other embodiments, the recombinant bacterium is a recombinant bacterium comprising an expression vector, and the recombinant bacterium is cultured under suitable conditions, e.g., with the addition of an appropriate amount of IPTG, at 16 ℃ to induce expression of the glycosyltransferase.
The invention also provides a preparation method of the glycosyltransferase, which comprises the following steps: constructing an expression vector of the coding gene of the glycosyltransferase, introducing the expression vector into expression host bacteria to obtain recombinant bacteria, culturing the recombinant bacteria and inducing protein expression, collecting thalli, and extracting and purifying protein.
The use of the glycosyltransferase in a glycosyl transfer reaction is also within the scope of the present invention.
The use of the glycosyltransferase in the synthesis of steroid saponins also falls within the scope of the present invention. The steroid saponin synthesis includes in vitro synthesis and in vivo synthesis, for example, synthesis of steroid saponins in microorganisms (e.g., yeast) or plants.
In some embodiments of the invention, diosgenin, pennogenin or neoacteoside is used in the synthesis of the steroid saponin, and a glucosyl group is introduced under the action of the glycosyltransferase, so as to generate the corresponding steroid saponin. Sapogenins used in the steroid saponin synthesis include, but are not limited to, diosgenin, pennogenin, and neoacteoside. The steroid saponins include, but are not limited to, trillin or pennogenin-3-O-glucoside.
The invention also provides a method for synthesizing paris polyphylla saponin V, which comprises the following steps: the glycosyltransferase reacts with diosgenin and UDP-Glc to generate the trillin; then, adding glycosyltransferase with an amino acid sequence shown as SEQ ID NO. 3 and UDP-Rha to continuously react with the trilobatin as a substrate to generate the paris polyphylla saponin V.
The invention also provides a method for synthesizing paris polyphylla saponin VI, which comprises the following steps: the glycosyltransferase reacts with the pennogenin and UDP-Glc to generate pennogenin-3-O-glucoside; then taking pennogenin-3-O-glucoside as a substrate, adding glycosyltransferase with an amino acid sequence shown as SEQ ID NO. 3 and UDP-Rha for continuous reaction, and generating paris saponin VI.
The glycosyltransferase provided by the invention is helpful for exploring the synthetic way of plant steroid saponins, and simultaneously provides gene resources for obtaining a large amount of paris polyphylla saponins or other saponins.
Drawings
FIG. 1 shows the electrophoresis patterns of amplification products of AsUGT73E5 and AsUGT73E1 genes. M is DL 2000;1 is AsUGT73E5 gene band; 2 is AsUGT73E1 gene band.
FIG. 2 shows SDS-PAGE patterns of prokaryotic expression of AsUGT73E5 and AsUGT73E1 proteins. M: a Page-roller protein molecular marker; 1: not induced; 2: whole cell proteins after IPTG induction; 3: cell supernatant after IPTG induction; 4: cell precipitation after IPTG induction; 5: purifying the supernatant GST column; 6: and (5) purifying protein, and concentrating by ultrafiltration.
FIG. 3 chromatogram of glycosylation products of AsUGT73E5, asUGT73E1 reaction with diosgenin. The retention time (min) is on the abscissa and the electrical signal (mAU) is on the ordinate. pGEX-empty: protein extracted and purified from cells containing pGEX-6P-1 empty vector after protein induction expression is used as a blank control; pGEX-AsUGT73E5: the cells containing pGEX-AsUGT73E5 vector are subjected to protein induction expression, and then extracted and purified to obtain AsUGT73E5 protein; cells containing pGEX-AsUGT73E1 vector are subjected to protein induction expression, and then extracted and purified AsUGT73E1 protein.
FIG. 4 mass spectrometry analysis of glycosylation products of AsUGT73E5, asUGT73E1 reactions with diosgenin. The abscissa is mass-to-charge ratio and the ordinate is ionic strength.
FIG. 5A chromatogram of the glycosylation products of AsUGT73E5, asUGT73E1 reactions with pennogenins. The retention time (min) is on the abscissa and the electrical signal (mAU) is on the ordinate. pGEX-empty: protein extracted and purified from cells containing pGEX-6P-1 empty vector after protein induction expression is used as a blank control; pGEX-AsUGT73E5: the cells containing pGEX-AsUGT73E5 vector are subjected to protein induction expression, and then extracted and purified to obtain AsUGT73E5 protein; cells containing pGEX-AsUGT73E1 vector are subjected to protein induction expression, and then extracted and purified AsUGT73E1 protein.
FIG. 6 mass spectrometry analysis of glycosylation products of AsUGT73E5, asUGT73E1 reactions with pennogenins. The abscissa is mass-to-charge ratio and the ordinate is ionic strength.
FIG. 7.AsUGT73E5 and AsUGT73E1 catalyze the process of steroidal sapogenin glycosylation.
FIG. 8A chromatogram of the glycosylation products of AsUGT73E5, asUGT73E1 reactions with neoacteoside. The retention time (min) is on the abscissa and the electrical signal (mAU) is on the ordinate. pGEX-empty: protein extracted and purified from cells containing pGEX-6P-1 empty vector after protein induction expression is used as a blank control; pGEX-AsUGT73E5: the cells containing pGEX-AsUGT73E5 vector are subjected to protein induction expression, and then extracted and purified to obtain AsUGT73E5 protein; cells containing pGEX-AsUGT73E1 vector are subjected to protein induction expression, and then extracted and purified AsUGT73E1 protein.
FIG. 9 mass spectrometry analysis of glycosylation products of AsUGT73E5, asUGT73E1 reactions with neoacteoside. The abscissa is mass-to-charge ratio and the ordinate is ionic strength.
Detailed Description
The invention is further described below in connection with the following examples, which are to be understood as merely illustrative and explanatory of the invention, and are not in any way limiting of the scope of the invention.
Experimental materials:
the plant material used in the following experiments was diploid oat (Avena strigosa, S75), a known variety described in non-patent document Papadopoulou et al 1999. The above-mentioned biological materials are also stored in the laboratory, and the applicant states that they can be issued to the public for verification experiments within twenty years from the date of application.
Coli (Escherichia coli) DH 5. Alpha. And Rosetta (DE 3) were purchased from Shanghai Biotechnology Inc. Cloning vector pClone007 Blunt Simple Vector was purchased from the biotechnology company of new industry, beijing, family. Prokaryotic expression vector pGEX-6P-1 is stored in the laboratory and is also commercially available.
PCR primer:
the main reagent comprises:
diosgenin: CAS number: 512-04-9, molecular formula: c (C) 27 H 42 O 3 The english name diongenin is purchased from the adult tuo pren technology development limited under the trade designation BP0504.
Pennogenin: CAS number: 507-89-1, molecular formula: c (C) 27 H 42 O 4 English name pennogin. The pennogenin used in the experiment was obtained by enzymatic separation and purification of paris polyphylla saponin VI, reference Li, w, wang, z, gu, j, chen, l, hou, w, jin, y.p.,&wang, Y.P. (2015) Bioconversion of ginsenoside Rd to ginsenoside M1 by snailase hydrolysis and its enhancement effect on insulin secretion in v.die Pharmazie,70:340-346. Pennogenin is also commercially available.
Neoacteoside aglycone: CAS number: 6811-35-4, molecular formula: c (C) 27 H 42 O 4 English name nuatigenin. The neotame sapogenin used in the experiments was obtained by enzymatic separation and purification of an oat saponin (avenacides) extract, and the extraction method of oat saponins (avenacides) was described in reference to Yang, j.l., wang, p., wu, w.b., zhao, y.t., idehen, e.,&Sang,S.M.(2016).Steroidal saponins in oat bran.Journal of Agricultural&food Chemistry, 64 (7): 1549-1556, the enzymatic separation and purification method is described in reference to Li, w, wang, z, gu, j, chen, l, hou, w, jin, y.p.,&Wang,Y.P.(2015).Bioconversion of ginsenoside Rd to ginsenoside M1 by snailase hydrolysis and its enhancement effect on insulin secretion in vitro.Die Pharmazie,70:340–346.。
UDP-Glucose (UDP-Glc): CAS number: 28053-08-9, molecular formula: c (C) 15 H 22 N 2 Na 2 O 17 P 2 Purchased from Beijing Cool Bo technologies Inc., cat# CU11611-500mg.
UDP-Rhamnose (UDP-Rha): CAS number: 1526988-33-9, molecular formula: c (C) 15 H 22 N 2 Na 2 O 16 P 2 The English name UDP 5' -biphospho-a-L-rhamnose, purchased from Souzhou Hanse Biotechnology Co.
All-grass of largeflower MeyerGlycoside: CAS number: 14144-06-0, molecular formula: c (C) 33 H 52 O 8 Purchased from chengdou pren technology development limited under the trade designation BP1124.
Paris polyphylla saponin V: CAS number: 19057-67-1, molecular formula: c (C) 39 H 62 O 12 Purchased from chengdoupren technology development limited under the trade designation BP1151.
Paris saponin VI: CAS number: 55916-51-3, molecular formula: c (C) 39 H 62 O 13 Purchased from chengdoupren technology development limited, cat No. BP1131.
Chromatographic methanol: purchased from merck, usa, cat No. 1.06007.4008.
Unless otherwise specified, the reagents used in the examples below are all conventional in the art and are commercially available or formulated according to conventional methods in the art; the experimental methods and conditions used are all those conventional in the art, and reference may be made to the relevant experimental manuals, well-known literature or manufacturer's instructions. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.
Example 1 discovery, cloning and expression of glycosyltransferase genes AsUGT73E5 and AsUGT73E1
1. Gene discovery
We used oat as the model material and found two glycosyltransferase genes, designated AsUGT73E5 and AsUGT73E1. The Open Reading Frame (ORF) of the AsUGT73E5 gene contains 1548 bases, the nucleotide sequence of which is shown as SEQ ID NO. 2, and the coded amino acid sequence of which is shown as SEQ ID NO. 1. The Open Reading Frame (ORF) of the AsUGT73E1 gene contains 1473 bases, the nucleotide sequence of which is shown as SEQ ID NO. 4, and the coded amino acid sequence of which is shown as SEQ ID NO. 3. By transcriptome-target metabolite association analysis (Pearson correlation), we found that expression of these two glycosyltransferases was highly synergistic with cholesterol synthesis in oat 10 tissues and thus likely involved in steroid saponin synthesis. To verify the function of these two glycosyltransferases in steroid saponin synthesis, we performed gene cloning and expression.
2. Gene cloning
2.1 extraction of total RNA from oat seedlings
RNA was extracted using the method of Tiangen biosystems RNAprep Pure Plant Kit (product number: DP 441) and was performed according to the instructions for the kit, as follows:
(1) 50-100mg oat leaves are rapidly ground into powder in liquid nitrogen, 450 mu L of RL (beta-mercaptoethanol is added before use) is added, and vortex violent shaking and mixing are carried out;
(2) Transferring the solution to a filter column CS, centrifuging at 12,000rpm for 2-5min, and sucking the supernatant in the collecting tube into a centrifugal tube of RNase-Free;
(3) Adding absolute ethyl alcohol with the volume of 0.5 times of the supernatant, mixing uniformly, transferring the obtained solution and the precipitate into an adsorption column CR3, centrifuging at 12,000rpm for 30-60sec, pouring out waste liquid, and placing the adsorption column CR3 into a collecting pipe;
(4) Adding 350 μL deproteinized liquid RW1 into the adsorption column CR3, centrifuging at 12,000rpm for 30-60sec, pouring out waste liquid, and placing the adsorption column CR3 back into a collecting pipe;
(5) Preparing DNase I working solution: taking 10 mu L of DNase I storage solution, putting the DNase I storage solution into a new RNase-Free centrifuge tube, adding 70 mu L of RDD buffer solution, and gently mixing the two;
(6) Adding 80 mu L of DNase I working solution into the center of an adsorption column CR3, and standing at room temperature for 15min;
(7) 350. Mu.L deproteinized liquid RW1 was added to the adsorption column CR3, centrifuged at 12,000rpm for 30-60sec, the waste liquid was discarded, and the adsorption column CR3 was returned to the collection tube;
(8) Adding 500 μl of rinsing liquid RW (ethanol is added before use) into the adsorption column CR3, standing at room temperature for 2min, centrifuging at 12,000rpm for 30-60sec, pouring out the waste liquid in the collection tube, and placing the adsorption column CR3 back into the collection tube, and repeating for one time;
(9) Centrifuging at 12,000rpm for 2min, pouring out the waste liquid, standing the adsorption column CR3 at room temperature for several minutes, and thoroughly airing the residual rinsing liquid;
(10) Placing the adsorption column CR3 into a new RNase-Free centrifuge tube, and suspending and dripping 30-100 μl RNase-Free ddH into the middle part of the adsorption film 2 O, standing at room temperature for 2minThe mixture was centrifuged at 12,000rpm for 2 minutes to obtain an RNA solution.
2.2 cDNA Synthesis
SuperScript III Rreverse Transcriptase kit (Invitrogen, cat# 18080085) was used and operated as described in the kit instructions:
(1) RNA template denaturation
Heated at 65℃for 5min, rapidly quenched on ice and allowed to stand on ice for 2min.
(2) First strand cDNA Synthesis
And (5) centrifuging for a short time and mixing uniformly. Reacting at 55deg.C for 60min, heating at 70deg.C for 15min to terminate the reaction, and preserving the product at-20deg.C.
2.3 Gene amplification of interest
The glycosyltransferase genes AsUGT73E5 and AsUGT73E1 coding region primers AsUGT73E5-ORF-F/R, asUGT E1-ORF-F/R are designed. PCR amplification was performed using 5-fold diluted oat seedling cDNA as a template, and the target gene was PCR amplified using primers AsUGT73E5-ORF-F/R, asUGT E1-ORF-F/R and 2X Phanta Max Master Mix high-fidelity enzyme (vazyme, cat# P515-02), respectively, with the following reaction system:
reaction conditions: pre-denaturation at 95℃for 3min; denaturation at 95℃for 30sec, annealing at 30sec at a primer Tm value (AsUGT 73E5-ORF-F/R: 60℃and AsUGT73E1-ORF-F/R:60 ℃) and extension at 72℃for 1min for a total of 33 cycles; thoroughly extend at 72℃for 7min. After the reaction, the PCR product was subjected to 1% agarose gel electrophoresis.
As a result, as shown in FIG. 1, 1 was AsUGT73E5,2 was AsUGT73E1, and the gene bands were about 1500bp in size.
2.4 DNA gel recovery
The target gene fragment was recovered using a Gel Extraction Kit (Omega, cat# D2500-02) kit, and the procedure was performed according to the kit instructions, as follows:
(1) Agarose gel containing the band of interest was cut out in an ultraviolet gum cutter, an equal volume of Binding Buffer was taken and the mixture incubated at 55℃for 7min until the gel was completely thawed.
(2) mu.L of the mixture was aspirated, transferred to a DNA adsorption column fitted with a 2mL collection tube, allowed to stand for 1min, centrifuged at 10,000g for 1min, and the filtrate was discarded.
(3) The adsorption column was placed in a recovery header, SPW Wash Buffer diluted with 700. Mu.L absolute ethanol was added, and the mixture was centrifuged at 10,000g for 1min, and the filtrate was discarded. Repeating once.
(4) The filtrate was discarded, the empty adsorbent column was placed back into the centrifuge tube and centrifuged at 12,000g for 2min.
(5) The empty adsorption column was placed in a sterilized 1.5mL centrifuge tube, the tube cap was opened and allowed to stand for 1min, 30. Mu.L of sterile water (preheated at 60 ℃) was added to the center of the adsorption membrane, and the mixture was allowed to stand at room temperature for 1min. The DNA was eluted by centrifugation at 12,000g for 1min.
2.5 cloning vector ligation
The gene of interest was cloned into pClone007 Blunt Simple Vector (Beijing engine family, cat# TSV-007 BS) and the reaction system was as follows:
reacting for 5min at room temperature.
2.6 E.coli transformation
(1) Taking 100 mu L of competent cells DH5 alpha (Shanghai Weidi organism) melted in an ice bath, adding target DNA, gently mixing, and standing in the ice bath for 30min;
(2) Heat shock is carried out for 60s in a water bath at the temperature of 42 ℃, and the centrifuge tube is rapidly transferred into an ice bath for 2min;
(3) 200 mu L of non-resistant sterile LB culture solution is added into the centrifuge tube, and after uniform mixing, the mixture is cultured for 1h at 180rpm in a shaking table at 37 ℃ to revive bacteria;
(4) Sucking the competent cells transformed in the previous step, adding the competent cells to LB agar medium containing ampicillin (Amp, screening concentration 100 mg/L) resistance, uniformly spreading the cells, drying the surface liquid of the medium, and culturing the flat plate at 37 ℃ overnight;
(5) Several single colonies are selected, added into 500 mu L LB liquid medium containing Amp resistance (100 mg/L), cultured for 4 hours at 37 ℃ and 180rpm, bacterial liquid PCR is identified, the identified primer is M13-F/R, positive clones are sent to Boston biotechnology limited company for sequencing, and cloning vectors pClone007-AsUGT73E5 and pClone007-AsUGT73E1 with correct sequences are obtained.
2.7 plasmid extraction
After bacterial protection of the correctly sequenced samples, plasmids were extracted using E.Z.N.A.plasmid Mini Kit I Kit (omega, cat# D6942-02) according to the instructions for use, using the following procedure:
(1) Taking 5mL of bacterial liquid (12-16 h) cultured overnight at 37 ℃, centrifuging at 10,000g for 1min, and discarding the supernatant;
(2) Adding 250 mu L of Solution I (RNase A is added) into the centrifuge tube, and blowing and uniformly mixing;
(3) Adding 250 μL Solution II, reversing for 4-6 times, mixing, standing for 2min to crack thallus (total time is less than 5 min);
(4) 350. Mu.L of Solution III was added and immediately turned upside down 6-8 times to allow the Solution to thoroughly mix, at which time a large amount of white flocculent precipitate appeared. Centrifuging at 13,000g for 10min;
(5) Placing the adsorption column in a collecting pipe, adding the supernatant after the suction and centrifugation into the adsorption column, centrifuging at 10,000g for 1min, and discarding the filtrate;
(6) 700. Mu.L of DNA Wash Buffer was added to the column, centrifuged at 10,000g for 1min, and the filtrate was discarded. Repeating the process once;
(7) Placing the empty adsorption column into a collecting pipe, centrifuging at 13,000g for 2min, transferring the adsorption column into a new 1.5mL centrifuge tube, opening a pipe cover to dry the adsorption column for 1min, and volatilizing the residual rinse liquid in the adsorption column;
(8) 50. Mu.L of sterile water preheated to 55℃was added to the center of the membrane of the adsorption column, left to stand for 2min and centrifuged at 13,000g for 1min. The adsorption column was discarded and the plasmid was stored at-20℃until use.
3. Protein expression
3.1 construction of prokaryotic expression vectors
PCR amplification was performed using pClone007 vector (pClone 007-AsUGT73E5 and pClone007-AsUGT73E 1) containing the target genes AsUGT73E5 and AsUGT73E1 open reading frame as templates, and recombinant primers AsUGT73E5-pGEXF/R, asUGT73E1-pGEXF/R were designed, and the reaction system and reaction conditions were the same as those described above 2.3, to obtain gene fragments for constructing expression vectors.
pGEX-6p-1 was used as a prokaryotic expression vector. pGEX-6p-1 vector was linearized with EcoRI (Thermo, cat# FD 0274) and SalI (Thermo, cat# FD 0644) endonucleases in the following system:
the reaction was terminated after 1 hour at 37 ℃.
PCR amplification products and linearized pGEX-6p-1 vector were recovered by agarose gel electrophoresis. The recovered gene fragment and linearized pGEX-6p-1 were subjected to homologous recombination according to the instructions using the ClonExpII One Step Cloning Kit kit (vacyme, cat# C112-02), and the ORFs of the genes AsUGT73E5, asUGT73E1 were cloned into the prokaryotic expression vector pGEX-6p-1, respectively, as follows:
the reaction is carried out for 30min at 37 ℃, the temperature is reduced to 4 ℃ or the reaction product is cooled on ice, and the obtained reaction product is transformed into escherichia coli DH5 alpha, and the transformation method is the same as 2.6. After overnight incubation, single colonies were picked, added to 500. Mu.L LB liquid medium containing Amp resistance (100 mg/L), incubated at 37℃for 4h at 180rpm, and identified by PCR in bacterial liquid, the identified primers were pGEX-F/R, and positive clones were sent to Bo XingKe Biotechnology Co., ltd for sequencing. The plasmid pGEX-AsUGT73E5/pGEX-AsUGT73E1 is extracted after the sample with correct sequencing result is preserved, and the plasmid extraction method is the same as the 2.7. Coli Rossetta (DE 3) expression competence (Shanghai-only organism) was transformed with the extracted plasmid, and pGEX-6p-1 empty vector transformation was set as a control, and the transformation method was the same as above 2.6.
3.2 protein-induced expression
The Rossetta (DE 3) bacterial solutions containing pGEX-AsUGT73E5/pGEX-AsUGT73E1/pGEX-6p-1 empty vector are respectively inoculated into 1L of LB liquid medium containing Amp resistance (100 mg/L) according to the volume ratio of 1:100, and cultured to OD by a shaking table at 37 ℃ at 200rpm 600 =0.6, 0.2mm iptg was added and induced overnight at 16 ℃ with shaker 160 rpm. The cells were collected by centrifugation at 4℃and 4,000rpm, and 10mL of a pre-chilled PBS solution (concentration 0.01M, pH 7.4, formulation: naCl 8.0g, KCl 0.2g, na) 2 HPO 4 1.44g,KH 2 PO 4 0.24g, distilled water was added to 1L) and resuspended and sonicated on ice until the solution was translucent. Centrifugation was carried out at 12,000rpm for 15min at 4℃and the supernatant and pellet were collected and detected by SDS-PAGE.
3.3 protein purification
Equilibration/wash (equilibration and wash were formulated as well) and eluents were formulated and 1mM DTT was added prior to use. Balancing/washing solution (1L): 140mM NaCl,2.7mM KCl,10mM Na 2 HPO 4 ,1.8mM KH 2 PO 4 pH 7.4. Eluent (1L): 50mM Tris-HCl,10mM reduced glutathione, pH 8.0.
(1) Glutathione Beads (Hengzhou Tiandi people and organisms, goods number: SA 008010) is put into a proper chromatographic column, and is balanced by a balancing solution with the volume of 5 times of the column volume, so that the filler is under the same buffer system as the target protein, and plays a role in protecting the protein;
(2) Adding the sample into balanced Glutathione Beads, ensuring that the target protein is fully contacted with Glutathione Beads, improving the recovery rate of the target protein, and collecting effluent;
(3) Washing with a 10-time column volume of impurity washing liquid to remove nonspecifically adsorbed impurity proteins, and collecting the impurity washing liquid;
(4) Collecting eluent by using eluent with the volume of 5 times of the column volume, namely the target protein component;
(5) Sequentially using balance liquid with the volume of 3 times of column and deionized water with the volume of 5 times of column to balance filling;
(6) The purified protein solution was added to a millipore 15mL ultrafilter tube (10 KD) at 4℃CThe sample was concentrated to 500. Mu.L by centrifugation at 4,000rpm, and 15mL of PBS phosphate buffer (concentration 0.01M, formulation: naCl 8.0g, KCl 0.2g, na) 2 HPO 4 1.44g,KH 2 PO 4 0.24g, pH 7.4 was adjusted, distilled water was added to 1L, and concentration was continued to 500. Mu.L. Repeating the process once;
(7) Purified protein was aspirated, diluted and glycerol was added to a final concentration of 10% and stored at-80 ℃.
SDS-PAGE detects purified proteins. As a result, as shown in FIG. 2, 1 is an uninduced whole cell protein; 2 is whole cell protein after IPTG induction; 3 is the cell supernatant after IPTG induction; 4 is cell precipitation after IPTG induction; 5 is a protein purified by a supernatant GST column; and 6, purifying protein after ultrafiltration concentration. The recombinant proteins all appeared to have a distinct band around 80kDa compared to the uninduced control samples. The AsUGT73E5 and AsUGT73E1 proteins respectively comprise 515 and 490 amino acids, and the molecular weights of the fused AsUGT73E5 and AsUGT73E1 proteins are 82.21KDa and 79.79KDa respectively.
Example 2 functional identification of glycosyltransferases AsUGT73E5 and AsUGT73E1
1. Enzyme Activity assay
(1) AsUGT73E5 catalyzed glycosylation reaction
1mM steroidal sapogenin (diosgenin/pennogenin/neoacteoside), 1mM UDP-Glucose (UDP-Glc), 50. Mu.L of purified glycosyltransferase AsUGT73E5 was accurately weighed, and dissolved in PBS phosphate buffer (concentration 0.01M, formulation: naCl 8.0g, KCl 0.2g, na) 2 HPO 4 1.44g,KH 2 PO 4 0.24g, pH 8.0 was adjusted, distilled water was added to 1L, and the final volume was brought to 300. Mu.L. After 2h of reaction at 37 ℃, adding an equal volume of methanol to stop enzyme activity, and dissolving the product in 500 mu L of chromatographic methanol to be detected after the product is dried under reduced pressure.
(2) AsUGT73E1 catalyzed glycosylation reaction
The glycosylation reaction in (1) was repeated, and the whole was concentrated and dried to use as a substrate, 1mM UDP-Rhamnose (UDP-Rha) was added, 50. Mu.L of purified glycosyltransferase AsUGT73E1 was dissolved in PBS phosphate buffer (pH 8.0) to give a final volume of 300. Mu.L. After 2h of reaction at 37 ℃, adding an equal volume of methanol to stop enzyme activity, and dissolving the product in 500 mu L of chromatographic methanol to be detected after the product is dried under reduced pressure.
HPLC and LC-Q-TOF identification of enzyme products
(1) Liquid chromatography
The experiment used a Thermo UltiMate 3000 liquid chromatograph, thermo Hypersil GOLD C 18 HPLC detection was performed on a liquid chromatography column (250 mm. Times.4.6 mm,5 μm). The mobile phases were water (a) and acetonitrile (B). Elution gradient: 0-6 min, 20-30% B; 6-15 min, 30-60% B; 15-21 min, 60-100% B; 21-30 min,100% B; 30-35 min, 100-20% B. The flow rate is 1mL/min, the column temperature is 30 ℃, the sample injection amount is 10 mu L, and the detection wavelength is as follows: 210nm.
(2) Mass spectrometry detection
The experiment was performed using a AB SCIEX TripleTOF 6600 ultra-high resolution mass spectrometer. Positive ion data acquisition mode, the condition is: capillary voltage 3.6kV, taper hole voltage 35kV, ion source temperature 105 ℃, desolventizing gas temperature 340 ℃, reverse taper hole airflow 55L/h, desolventizing gas 650L/h, extraction taper hole 4V. Mass-to-charge ratio data scan range: 50-1500m/z.
Results and analysis
The product of reaction of AsUGT73E5 protein and diosgenin, UDP-Glc is dried by a vacuum concentrator, added with 500 mu L of chromatographic methanol for dissolution, filtered by a 0.22 mu m filter membrane and detected by HPLC. As shown in FIG. 3, the product of AsUGT73E5 showed a new peak (product 1) at 22.3min compared to the empty reaction, which was the same as the peak time of the trillin standard. The sample was recovered, and the reaction was continued by adding AsUGT73E1 protein and UDP-Rha, and a new product peak (product 2) was observed at 20.7min, which time was consistent with the rhizoma paridis saponin V standard. TOF positive ion scanning mode detection is shown in FIG. 4, the molecular weights of product 1 and product 2 are 577.38 (M+H) + ) And 723.43 (M+H) + ) The molecular weight of the Chinese medicinal materials is consistent with that of the trilobatin (576.3) and the paris polyphylla saponin V (722.4), which shows that the paris polyphylla saponin V is generated after the continuous catalysis of the AsiGT 73E5 and the AsiGT 73E1 by the diosgenin.
After HPLC detection of the product of the reaction of AsUGT73E5 protein with pennogenin, UDP-Glc (FIG. 5), the product of AsUGT73E5 was compared with the empty reactionA new peak (product 3) appears at 18.8 min. The sample was recovered, and the reaction was continued by adding AsUGT73E1 protein and UDP-Rha, and a new product peak (product 4) was observed at 17.1min, which time was consistent with the Paris polyphylla saponin VI standard. TOF positive ion scanning mode detection is shown in FIG. 6, the molecular weights of product 3 and product 4 are 593.37 (M+H) + ) And 739.43 (M+H) + ) Consistent with the molecular weight of the pennogenin-3-O-glucoside (592.3) and the paris saponin VI (738.4), the pennogenin is proved to generate the paris saponin VI after being continuously catalyzed by the AsUGT73E5 and the AsUGT73E1. The process of the AsUGT73E5 and AsUGT73E1 proteins catalyzing the glycosylation of steroidal sapogenins is shown in figure 7.
The product of reaction of AsUGT73E5 protein with neoacteosin and UDP-Glc is dried by a vacuum concentrator, dissolved by adding 500 mu L of chromatographic methanol, and filtered by a 0.22 mu m filter membrane for HPLC detection. As shown in FIG. 8, the product of AsUGT73E5 showed a new peak (product 5) at 16.7min, compared to the empty reaction. The sample was recovered and the reaction was continued by adding AsUGT73E1 protein and UDP-Rha, and a second product peak (product 6) was present at 15.6 min. TOF positive ion scanning mode detection is shown in FIG. 9, the molecular weights of product 5 and product 6 are 593.37 (M+H) + ) And 739.43 (M+H) + ) Indicating that the neotame sapogenin generates corresponding glycosylation products after being continuously catalyzed by AsUGT73E5 and AsUGT73E1.
Reference is made to:
Cárdenas,P.D.,Sonawane,P.D.,Heinig,U.,Bocobza,S.E.,Burdman,S.,&Aharoni,A.(2015). The bitter side of the nightshades:Genomics drives discovery in Solanaceae steroidal alkaloid metabolism.Phytochemistry,113,24-32.
Christ,B.,Xu,C.C.,Xu,M.L.,Li,F.S.,Wada,N.,Mitchell,A.J.,…&Weng,J.K.(2019). Repeated evolution of cytochrome P450-mediated spiroketal steroid biosynthesis in plants.Nature Communications,10,3206.
Deng,D.,Lauren,D.R.,Cooney,J.M.,Jensen,D.J.,Wurms,K.V.,Upritchard,J.E.,…&Li,M.Z. (2008).Antifungal saponins from Paris polyphylla Smith.Planta Medica,74(11),1397-1402.
Gong,G.H.,Qin,Y.,Huang,W.,Zhou,S.,Wu,X.H.,Yang,X.H,…&Li.D.(2010).Protective effects of diosgenin in the hyperlipidemic rat model and in human vascular endothelial cells against hydrogen peroxide-induced apoptosis.Chemico-Biological Interactions,184(3), 366-375.Journal of agricultural and food chemistry,64(7),1549-1556.
He,J.L.,Yu,S.,Guo,C.J.,Tan,L.,Song,X.M.,Wang,M.,…&Peng,C.(2019).Polyphyllin I induces autophagy and cell cycle arrest via inhibiting PDK1/Akt/mTOR signal and downregulating cyclin B1 in human gastric carcinoma HGC-27cells.Biomedicine&Pharmacotherapy,117,109189.
Louveau,T.,Orme,A.,Pfalzgraf,H.,Stephenson,M.J.,Melton,R.,Saalbach,G.,...&Langdon,T. (2018).Analysis of two new arabinosyltransferases belonging to the carbohydrate-active enzyme(CAZY)glycosyl transferase family1 provides insights into disease resistance and sugar donor specificity.The Plant Cell,30(12),3038-3057.
Orme,A.,Louveau,T.,Stephenson,M.J.,Appelhagen,I.,Melton,R.,Cheema,J.,…&Osbourn, A.(2019).A noncanonical vacuolar sugar transferase required for biosynthesis of antimicrobial defense compounds in oat.Proceedings of the National Academy of Sciences, 201914652.
Papadopoulou,K.,Melton,R.E.,Leggett,M.,Daniels,M.J.,&Osbourn,A.E.(1999). Compromised disease resistance in saponin-deficient plants.Proceedings of the National Academy of Sciences,96(22),12923-12928.
Qin,X.J.,Sun,D.J.,Ni,W.,Chen,C.X.,Hua,Y.,He,L.,&Liu,H.Y.(2012).Steroidal saponins with antimicrobial activity from stems and leaves of Paris polyphylla var.yunnanensis.Steroids,77(12),1242-1248.
Teng,J.F.,Qin,D.L.,Mei,Q.B.,Qiu,W.Q.,Pan,R.,Xiong,R.,…&Wu.,A.G.(2019). Polyphyllin VI,a saponin from Trillium tschonoskii Maxim.induces apoptotic and autophagic cell death via the ROS triggered mTOR signaling pathway in non-small cell lung cancer. Pharmacological Research,147,104396.
Vincken,J.P.,Heng,L.,de Groot,A.,&Gruppen,H.(2007).Saponins,classification and occurrence in the plant kingdom.Phytochemistry,68(3),275-297.
Wang,G.X.,Han,J.,Zhao,L.W.,Jiang,D.X.,Liu,Y.T.,&Liu,X.L.(2010).Anthelmintic activity of steroidal saponins from Paris Polyphylla.Phytomedicine,17(14),1102-1105.
Xue,Z.Y.,Tan,Z.W.,Huang,A.C.,Zhou,Y.,Sun,J.C.,Wang,X.N.,…&Qi,X.Q.(2018). Identification of key amino acid residues determining product specificity of 2,3-oxidosqualene cyclase in Oryza species.New Phytologist,218(3):1076-1088.
Yan,Y.M.,Shen,X.,Cao,Y.K.,Zhang,J.J.,Wang,Y.,&Cheng,Y.X.(2020).Discovery of Anti-2019-nCoV Agents from 38 Chinese Patent Drugs toward Respiratory Diseases via Docking Screening.Preprints,2020020254(doi:10.20944/preprints202002.0254.v2).
Zhang,C.,Jia,X.J.,Bao,J.L.,Chen,S.H.,Wang,K.,Zhang,Y.L.,…&He,C.W.(2016). Polyphyllin VII induces apoptosis in HepG2 cells through ROS-mediated mitochondrial dysfunction and MAPK pathways.BMC Complementary and Alternative Medicine,16(58)。
sequence listing
<110> university of northeast forestry
<120> oat glycosyltransferase AsUGT73E5 and its use in steroid saponin synthesis
<130> P200849-DBL
<160> 16
<170> SIPOSequenceListing 1.0
<210> 1
<211> 515
<212> PRT
<213> oat (Avena sativa l.)
<400> 1
Met Ala Asp Leu His Phe Leu Val Val Pro Leu Ala Ala Gln Gly His
1 5 10 15
Ile Ile Pro Met Val Asp Val Ala Arg Leu Leu Ala Ala Arg Gly Ser
20 25 30
Arg Val Thr Val Val Thr Thr Pro Val Asn Ala Ala Arg Asn Arg Ala
35 40 45
Ala Val Asp Gly Ala Arg Lys Ala Gly Leu Ala Val Glu Leu Leu Glu
50 55 60
Leu Pro Phe Pro Ser Ala Gln Leu Gly Leu Pro Glu Gly Leu Glu Ala
65 70 75 80
Val Asp Gln Leu Asn Gly Gln Pro Pro Glu Ile Ser Ile Gly Leu Phe
85 90 95
Lys Ala Ile Trp Thr Leu Ala Gly Pro Leu Glu Glu Tyr Leu Arg Ala
100 105 110
Leu Pro Arg Leu Pro Asp Cys Leu Val Ala Asp Leu Cys Asn Pro Trp
115 120 125
Thr Ala Pro Val Cys Glu Arg Leu Gly Ile Pro Arg Leu Val Met His
130 135 140
Cys Pro Ser Ala Tyr Phe Gln Leu Ala Val His Arg Leu Asn Glu His
145 150 155 160
Gly Val Tyr Gly Gly Gly Val Glu Asp Tyr Asp Pro Thr Pro Ile Glu
165 170 175
Val Pro Gly Phe Pro Val Arg Ala Phe Gly Ser Lys Thr Thr Met Arg
180 185 190
Gly Phe Phe Gln Tyr Pro Gly Val Glu Gln Glu His Leu Glu Ala Leu
195 200 205
His Ala Glu Ala Thr Ala Asp Gly Leu Leu Phe Asn Ser Phe Arg Ala
210 215 220
Ile Glu Ala Asp Phe Leu Asp Ala Tyr Ala Ala Ala Leu Gly Lys Thr
225 230 235 240
Thr Trp Ala Val Gly Pro Thr Ala Leu Val Asn Asp Thr Thr Thr Thr
245 250 255
Thr Ala Ser Ser Arg Ser Ser Thr Ile Val Ser Trp Leu Asp Ala Arg
260 265 270
Pro Pro Asp Ser Val Leu Tyr Val Ser Phe Gly Ser Ile Ser Leu Leu
275 280 285
Ser Ala Lys Gln Leu Ala Lys Leu Ala Asp Gly Leu Glu Ala Ser Gly
290 295 300
Arg Pro Phe Val Trp Ala Ile Lys Glu Asp Lys Ala Asp Ala Ala Val
305 310 315 320
Arg Ser Gln Leu Asp Glu Glu Gly Gly Phe Glu Ala Arg Val Lys Asp
325 330 335
Arg Gly Leu Leu Val Arg Gly Trp Ala Pro Gln Val Ala Ile Leu Ser
340 345 350
His Pro Ala Val Gly Gly Phe Leu Thr His Cys Gly Trp Asn Ser Thr
355 360 365
Leu Glu Ala Leu Ser His Gly Val Pro Ala Leu Thr Trp Pro Thr Asn
370 375 380
Ala Asp Gln Phe Cys Ser Glu Gln Val Ile Val Asp Val Leu Asp Val
385 390 395 400
Gly Val Arg Ser Gly Val Lys Ile Pro Ala Leu Tyr Val Pro Pro Glu
405 410 415
Ala Glu Gly Val Gln Val Glu Ser Gly Asp Val Glu Arg Ala Ile Val
420 425 430
Glu Leu Met Asp Gly Gly Pro Glu Gly Ala Ala Arg Arg Ala Arg Ala
435 440 445
Arg Lys Ile Ala Val Glu Ala Lys Ala Ala Met Glu Glu Gly Gly Thr
450 455 460
Ser His Ser Asp Leu Thr Asp Met Ile Arg His Val Ser Glu Leu Ser
465 470 475 480
Arg Lys Lys Arg Leu Gln Leu Glu Thr Ala Asp Ala Thr Cys Glu Glu
485 490 495
Ala Thr Arg Ala Ala Asp Asn Ala Ala Ala Val Leu Pro Leu Leu Ser
500 505 510
Gln Ala Asn
515
<210> 2
<211> 1548
<212> DNA
<213> oat (Avena sativa l.)
<400> 2
atggcggatc tacacttcct ggtcgtgccg ctggcggcgc agggccacat catccccatg 60
gtggacgtgg cgcgcctcct cgccgcgcgt ggctcgcggg tcaccgtcgt caccacgccc 120
gtcaacgccg cgcgcaaccg ggccgccgtg gacggcgcca ggaaggcggg cctcgccgtc 180
gagctcctgg agctcccgtt ccccagcgcg cagctcggcc tgcctgaggg cctggaggcc 240
gtcgaccagc tgaacgggca gccacctgaa atctccatcg gcctcttcaa ggccatctgg 300
accctggccg gaccgctgga ggagtacctc cgcgcgctgc cgcgcctgcc ggactgcctc 360
gtcgccgact tgtgcaaccc ttggacggcg ccggtctgcg agcgcctcgg catcccgagg 420
ctggtgatgc actgcccgtc cgcctacttc cagctcgccg tgcaccgcct gaacgagcac 480
ggcgtgtacg gcggaggcgt cgaggactac gaccccacgc ctatcgaggt gccgggcttc 540
cccgtgcgcg ccttcgggag caagaccacc atgcggggct tcttccagta ccccggcgtc 600
gagcaggagc accttgaagc gctccacgcc gaggccaccg ccgacggcct gctcttcaac 660
agcttccgcg ccatcgaggc cgacttcctc gacgcctacg cggcggcgct cggcaagacg 720
acgtgggccg tcgggccgac cgccttggtg aacgacacca ccaccaccac cgcctcctcg 780
aggtcgagca ccatcgtgtc gtggctcgac gcccggccgc cggactccgt gctgtacgtc 840
agcttcggca gcatctccct gctgtcggcg aagcagctgg cgaagctcgc ggacgggctg 900
gaggcgtcgg ggcggccgtt cgtgtgggcg atcaaggagg acaaggcgga cgcggcggtg 960
cggtcgcagc tggacgagga gggagggttc gaggcgcggg tcaaggacag gggcctcctg 1020
gtgcgcgggt gggcgccgca ggtggccatc ctctcgcacc cggcggtggg cggcttcctc 1080
acgcactgcg gctggaacag cacgctggag gccctctcac acggcgtgcc ggcgctgacg 1140
tggcccacca acgccgacca gttctgcagc gagcaggtga tcgtggacgt cctcgacgtc 1200
ggcgtcaggt ctggcgtcaa gatcccggcc ctgtacgtgc ccccggaggc cgagggggtg 1260
caggtggaga gcggcgacgt ggagagggcg atcgtggagc tgatggacgg cgggccggag 1320
ggagcggcga ggagggccag ggcaaggaag attgccgtgg aggccaaggc ggccatggag 1380
gaaggcggga cgtcgcactc cgacctaacg gacatgatcc gccatgtctc ggagctgtcc 1440
aggaagaaga ggctccagct cgagacagcc gacgcgacct gtgaagaagc aacaagagca 1500
gcagacaacg ctgccgcagt actgcctcta ctgtcccaag ctaattaa 1548
<210> 3
<211> 490
<212> PRT
<213> oat (Avena sativa l.)
<400> 3
Met Val Ala Ser Arg Val Lys Lys Leu Arg Val Leu Leu Ile Pro Phe
1 5 10 15
Phe Ala Thr Ser His Ile Glu Pro Tyr Thr Glu Leu Ala Ile Arg Leu
20 25 30
Ala Gly Ala Lys Pro Asp Tyr Ala Val Glu Pro Thr Ile Ala Val Thr
35 40 45
Pro Ala Asn Val Pro Ile Val Gln Ser Leu Leu Glu Arg Arg Gly Gln
50 55 60
Gln Gly Arg Ile Lys Ile Ala Thr Tyr Pro Phe Pro Ala Val Glu Gly
65 70 75 80
Leu Pro Ala Gly Val Glu Asn Leu Gly Lys Val Ala Ala Ala Asp Ala
85 90 95
Trp Arg Ile Asp Ala Ala Ala Ile Ser Asp Thr Leu Met Arg Pro Ala
100 105 110
Gln Glu Ala Leu Val Arg Ala Gln Ser Pro Asp Ala Met Val Ala Asp
115 120 125
Pro His Phe Ser Trp Gln Ala Gly Ile Ala Ala Asp Leu Gly Val Pro
130 135 140
Leu Val Ser Phe Ser Val Val Gly Ala Phe Ser Gly Leu Val Met Gly
145 150 155 160
Lys Leu Met Ala Tyr Gly Ala Val Glu Asp Gly Glu Asp Ala Val Thr
165 170 175
Ile Pro Gln Phe Pro Leu Pro Glu Ile Arg Ile Pro Val Thr Glu Leu
180 185 190
Pro Glu Phe Leu Arg Thr His Leu Leu Glu Arg Asp Gly Lys Asp Val
195 200 205
Asp Ser Ile Gly Lys Val Ser Val Gly Gln Asn Phe Gly Leu Ala Ile
210 215 220
Asn Thr Ala Ser His Leu Glu Gln Gln Tyr Cys Glu Met His Thr Ser
225 230 235 240
Gly Gly Gln Ile Lys Arg Ala Tyr Phe Val Gly Pro Leu Ser Leu Gly
245 250 255
Ala Glu Ala Val Ala Pro Gly Gly Gly Gly Gly Glu Thr Gln Ala Pro
260 265 270
Pro Cys Ile Arg Trp Leu Asp Ser Lys Pro Asp Arg Ser Val Val Tyr
275 280 285
Leu Cys Phe Gly Ser Leu Thr His Val Ser Asp Ala Gln Leu Asp Glu
290 295 300
Leu Ala Leu Gly Leu Glu Ala Ser Gly Lys Ala Phe Leu Trp Val Val
305 310 315 320
Arg Ala Ala Glu Ala Trp Arg Pro Pro Ala Gly Trp Ala Glu Arg Val
325 330 335
Gln Asp Arg Gly Met Leu Leu Thr Ala Trp Ala Pro Gln Thr Ala Ile
340 345 350
Leu Gly His Arg Ala Val Gly Ala Phe Val Thr His Cys Gly Trp Asn
355 360 365
Ser Val Leu Glu Ala Val Ala Ala Gly Leu Pro Val Leu Thr Trp Pro
370 375 380
Met Val Phe Glu Gln Phe Ile Thr Glu Arg Leu Val Thr Glu Val Met
385 390 395 400
Gly Ile Gly Glu Arg Phe Trp Pro Glu Gly Ala Gly Arg Arg Ser Thr
405 410 415
Arg Tyr Glu Glu His Gly Leu Val Pro Ala Glu Asp Val Ala Arg Ala
420 425 430
Val Thr Thr Phe Met Cys Pro Gly Gly Ala Gly Asp Ala Lys Arg Gln
435 440 445
Arg Ala Met Glu Leu Ala Ala Glu Ser Arg Ala Ala Met Ala Glu Gly
450 455 460
Gly Ser Ser His Arg Asp Leu Cys Arg Leu Val Asp Asp Leu Val Ala
465 470 475 480
Ala Lys Leu Glu Arg Glu Gln Val Pro Ser
485 490
<210> 4
<211> 1473
<212> DNA
<213> oat (Avena sativa l.)
<400> 4
atggttgcca gccgtgtgaa gaagctgcgt gtcctgctca ttcccttctt cgcgacaagc 60
cacatcgagc cctacaccga gctcgccatc cgcctcgccg gcgccaagcc ggactacgcc 120
gtggagccaa caattgcggt gacgccggcg aacgtcccaa tcgtccagtc cttgctggag 180
cgacgcggac agcaggggcg catcaagatc gcgacgtacc cgttcccggc cgtggagggc 240
ctcccggcgg gcgtggagaa cctgggcaag gtcgcggcgg ccgacgcctg gcgcatcgac 300
gcggccgcca tcagcgacac cctgatgcgg cccgcgcagg aggcgctggt gagggcgcag 360
tcccccgacg ccatggtcgc cgacccgcac ttctcctggc aggccggcat cgccgccgat 420
ctgggcgtgc cgctggtgtc gttcagcgtg gtgggcgcct tctcggggct cgtcatgggc 480
aaactcatgg cctacggcgc cgtcgaggac ggcgaagacg ccgttacgat ccctcagttt 540
ccccttccgg agatacggat accggtgacc gagctgccgg agttcctgag gacccacctg 600
ctcgagcgtg acgggaagga cgtcgatagc atcggcaaag tttcggtggg acagaatttc 660
ggcctcgcca tcaacacggc gtcgcacctg gagcagcagt actgcgagat gcacaccagc 720
ggcggccaaa tcaagcgagc ctacttcgtg gggcccctct cgctgggagc cgaagcagtt 780
gcccccggcg gcggcggcgg cgagacacag gcgccgccgt gcatccgttg gctggactcg 840
aagccggacc ggtcggtggt gtacctgtgc ttcgggagcc tgacccacgt ctcggacgcg 900
cagctggacg agctggctct cgggctggag gcgtccggga aggcgttcct gtgggtggtg 960
agggcggcgg aggcgtggcg gccgccggcg gggtgggcgg agcgcgtgca ggacaggggg 1020
atgctcctga ccgcctgggc cccgcagacc gccatcctgg gccaccgcgc cgtgggcgcc 1080
ttcgtgacgc actgcgggtg gaactcggtg ctggaggcgg tggcggcggg gctgccggtg 1140
ctgacgtggc cgatggtgtt cgagcagttc atcacggaga ggctggtgac ggaggtgatg 1200
gggatcgggg agcggttctg gccggagggc gccggacggc ggagcaccag gtacgaagag 1260
cacgggctgg tcccggcgga ggacgtggcg cgggcggtga caacgttcat gtgccccgga 1320
ggagcagggg acgccaagag gcagagggcg atggagctcg ccgccgagtc tcgtgcggcc 1380
atggcggaag gaggctcgtc gcaccgtgat ctgtgccgcc tcgttgacga tctcgtcgca 1440
gctaagctag agagagagca ggtgcctagc tag 1473
<210> 5
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 5
atggcggatc tacacttcct 20
<210> 6
<211> 22
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 6
ttaattagct tgggacagta ga 22
<210> 7
<211> 19
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 7
atggttgcca gccgtgtga 19
<210> 8
<211> 19
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 8
ctagctaggc acctgctct 19
<210> 9
<211> 42
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 9
gcccctggga tccccggaat tcatggcgga tctacacttc ct 42
<210> 10
<211> 44
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 10
cgatgcggcc gctcgagtcg acttaattag cttgggacag taga 44
<210> 11
<211> 41
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 11
gcccctggga tccccggaat tcatggttgc cagccgtgtg a 41
<210> 12
<211> 41
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 12
cgatgcggcc gctcgagtcg acctagctag gcacctgctc t 41
<210> 13
<211> 18
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 13
tgtaaaacga cggccagt 18
<210> 14
<211> 18
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 14
caggaaacag ctatgacc 18
<210> 15
<211> 21
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 15
cagcaagtat atagcatggc c 21
<210> 16
<211> 20
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 16
ggagctgcat gtgtcagagg 20
Claims (10)
1.A glycosyltransferase has an amino acid sequence shown in SEQ ID NO. 1.
2.A gene encoding the glycosyltransferase of claim 1.
3. The gene according to claim 2, characterized in that: the nucleotide sequence of the gene is shown as SEQ ID NO. 2.
4. An expression cassette, vector or recombinant bacterium comprising the gene of claim 2 or 3.
5. The method for producing glycosyltransferase of claim 1, comprising the steps of: constructing the expression vector of the gene as claimed in claim 2 or 3, introducing the expression vector into an expression host bacterium to obtain recombinant bacterium, culturing the recombinant bacterium and inducing protein expression, collecting the thallus, and extracting and purifying the protein.
6. The use of a glycosyltransferase of claim 1 in a glycosyltransferase reaction wherein the glycosyltransferase has diosgenin, pennogenin or neoacteoside as a substrate.
7. Use of a glycosyltransferase according to claim 1 in the synthesis of a steroid saponin, wherein the glycosyltransferase uses diosgenin, pennogenin or neoacteoside as a substrate.
8. Use according to claim 7, characterized in that: the synthesis of the steroid saponin adopts diosgenin, pennogenin or neotame sapogenin, and glucose radical is introduced under the action of glycosyltransferase, so that the corresponding steroid saponin is generated.
9.A method for synthesizing paris polyphylla saponin V comprises the following steps: reacting the glycosyltransferase of claim 1 with diosgenin and UDP-Glc to produce trillin; then, adding glycosyltransferase with an amino acid sequence shown as SEQ ID NO. 3 and UDP-Rha to continuously react with the trilobatin as a substrate to generate the paris polyphylla saponin V.
10. A method for synthesizing paris polyphylla saponin VI comprises the following steps: reacting the glycosyltransferase of claim 1 with pennogenin, UDP-Glc to produce pennogenin-3-O-glucoside; then taking pennogenin-3-O-glucoside as a substrate, adding glycosyltransferase with an amino acid sequence shown as SEQ ID NO. 3 and UDP-Rha for continuous reaction, and generating paris saponin VI.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011250301.1A CN114480322B (en) | 2020-11-11 | 2020-11-11 | Oat glycosyltransferase AsUGT73E5 and application thereof in steroid saponin synthesis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011250301.1A CN114480322B (en) | 2020-11-11 | 2020-11-11 | Oat glycosyltransferase AsUGT73E5 and application thereof in steroid saponin synthesis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114480322A CN114480322A (en) | 2022-05-13 |
CN114480322B true CN114480322B (en) | 2023-11-21 |
Family
ID=81491290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011250301.1A Active CN114480322B (en) | 2020-11-11 | 2020-11-11 | Oat glycosyltransferase AsUGT73E5 and application thereof in steroid saponin synthesis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114480322B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004261104A (en) * | 2003-03-03 | 2004-09-24 | Institute Of Physical & Chemical Research | GLYCOSYLATED ENZYME GENE SaGT6 AND UTILIZATION THEREOF |
CN103710318A (en) * | 2012-09-29 | 2014-04-09 | 中国科学院上海生命科学研究院 | Method for producing stevioside compounds by using microorganisms |
CN109420165A (en) * | 2017-08-23 | 2019-03-05 | 中国人民解放军军事医学科学院生物工程研究所 | Prevent and treat Acinetobacter bauamnnii associated diseases vaccine and preparation method thereof |
-
2020
- 2020-11-11 CN CN202011250301.1A patent/CN114480322B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004261104A (en) * | 2003-03-03 | 2004-09-24 | Institute Of Physical & Chemical Research | GLYCOSYLATED ENZYME GENE SaGT6 AND UTILIZATION THEREOF |
CN103710318A (en) * | 2012-09-29 | 2014-04-09 | 中国科学院上海生命科学研究院 | Method for producing stevioside compounds by using microorganisms |
CN109420165A (en) * | 2017-08-23 | 2019-03-05 | 中国人民解放军军事医学科学院生物工程研究所 | Prevent and treat Acinetobacter bauamnnii associated diseases vaccine and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN114480322A (en) | 2022-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kim et al. | Biosynthesis and biotechnological production of ginsenosides | |
Luo et al. | Analysis of the transcriptome of Panax notoginseng root uncovers putative triterpene saponin-biosynthetic genes and genetic markers | |
Niu et al. | Expression profiling of the triterpene saponin biosynthesis genes FPS, SS, SE, and DS in the medicinal plant Panax notoginseng | |
Ciura et al. | Next-generation sequencing of representational difference analysis products for identification of genes involved in diosgenin biosynthesis in fenugreek (Trigonella foenum-graecum) | |
EP2900812B1 (en) | Novel udp-glycosyltransferase derived from ginseng and use thereof | |
EP2900813B1 (en) | Novel udp-glycosyltransferase derived from ginseng and use thereof | |
Yin et al. | A cytochrome P450 monooxygenase responsible for the C-22 hydroxylation step in the Paris polyphylla steroidal saponin biosynthesis pathway | |
CN110343678A (en) | A kind of panax japonicus majoris glycosyl transferase UGTPjm1 gene and the application on preparation ginsenoside Ro | |
Abbas et al. | Cloning, functional characterization and expression analysis of LoTPS5 from Lilium ‘Siberia’ | |
Huang et al. | Production of oleanane-type sapogenin in transgenic rice via expression of β-amyrin synthase gene from Panax japonicus CA Mey | |
Song et al. | Characterization of three Paris polyphylla glycosyltransferases from different UGT families for steroid functionalization | |
Yin et al. | Ginseng omics for ginsenoside biosynthesis | |
Jiang et al. | Key glycosyltransferase genes of Panax notoginseng: identification and engineering yeast construction of rare ginsenosides | |
Cammareri et al. | Molecular characterization of β-amyrin synthase from Aster sedifolius L. and triterpenoid saponin analysis | |
Yao et al. | Engineering of triterpene metabolism and overexpression of the lignin biosynthesis gene PAL promotes ginsenoside Rg3 accumulation in ginseng plant chassis | |
Kumar | Improving secondary metabolite production in tissue cultures | |
Yin et al. | Deciphering the network of cholesterol biosynthesis in Paris polyphylla laid a base for efficient diosgenin production in plant chassis | |
Tang et al. | Ginsenosides accumulation and related genes expression in different underground parts of Panax notoginseng during maturation stage | |
Chen et al. | Unraveling the serial glycosylation in the biosynthesis of steroidal saponins in the medicinal plant Paris polyphylla and their antifungal action | |
CN114480322B (en) | Oat glycosyltransferase AsUGT73E5 and application thereof in steroid saponin synthesis | |
CN114480323B (en) | Oat glycosyltransferase AsUGT73E1 and application thereof in steroid saponin synthesis | |
CN115247159B (en) | Paris polyphylla glycosyltransferase PpUGT80A33 and PpUGT80A34 and application thereof | |
CN114807075B (en) | Glycosyltransferase PpUGT73E5 and application thereof in paris polyphylla saponin synthesis | |
Zhang et al. | Comparative transcriptome analysis and identification of candidate genes involved in cucurbitacin IIa biosynthesis in Hemsleya macrosperma | |
Thirugnanasambantham et al. | In vitro and omics technologies opens a new avenue for deciphering withanolide metabolism in Withania somnifera |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |